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The primary purpose of this quality improvement research is to design a structured study 
to improve clinical process and outcomes in healthcare. This thesis presents a framework 
for quality improvement and evaluation of a clinical decision support system in cross-
cultural settings. The framework extends a SPO model to a SPOE model, combines with 
the CRISP-DM model and the Patient Journey Model Architecture (PaJMa); with the 
purpose of providing a new approach for quality improvement in a NICU environment 
and evaluating the effectiveness of the CDSS which was implemented as a tool to support 
the quality improvement research. The approach is extending mining of physiological 
data in real-time to develop a new clinical practice model that can be used to improve the 
process of caring, provide patient-central care, support clinical decision- making, and 
increase efficacy in acute care settings. This thesis demonstrates the framework within the 
neonatal care units through a case study of late onset neonatal sepsis in Canada and 
China, uses the CRISP-DM for the process mining and PaJMa for presentation of routine 
clinical practice and clinical process improvement. This research is extending 
McGregor’s research “A process mining driven framework for clinical guideline 
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A Framework for Quality Improvement and Evaluation of a Clinical 
Decision Support System in NICU Environment in Cross-Cultural Settings 
Chapter1: Introduction 
This thesis presents a framework for the implementation and evaluation of clinical 
decision support systems (CDSSs) to support and measure quality improvement (QI) in 
healthcare. It enriches quality improvement using techniques from patient journey 
modelling (PaJMa) and knowledge discovery. The framework is demonstrated in this 
research through a case study in a neonatal intensive care unit (NICU) in cross-cultural 
settings. The overall goals and objectives of the research are to define a framework for QI 
that improves the clinical process by utilizing CDSSs that specifically use real-time 
sensor data obtained from various monitoring and supportive medical devices and to 
evaluate the effectiveness of the CDSS on clinical outcomes. This research is motivated 
by a number of factors including recent dramatic advanced information technology (IT) 
application in acute care settings together with rapid growth in the availability of 
physiological data from the medical devices used to monitor neonates in the critical care 
environment; existing issues in terms of QI in the NICU environment, inefficient 
utilization of physiological data to support clinical decision-making, and the needs of 
measurement of the CDSS impact on outcomes. This research is further motivated by 
potential benefits to the neonatal critical care domain where quality of care can be 
continually improved by new approaches to redesign the clinical process and the patient 
journey, develop a new clinical practice model, and to evaluate the CDSS in actual 
practical settings through analysis of physiological data in real-time. 
Quality of care has been defined as “the degree to which health services for individuals 
and populations increase the likelihood of desired health outcomes and are consistent with 
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current professional knowledge” (Lohr, 1990, p.707). There are three key themes that are 
emphases in the definition of quality: individual, desired health outcomes, and 
professional knowledge (Lohr, 1990). Based on this definition, in this thesis, quality of 
care defines: 1) the individual as an unique patient on whom the provided health services 
should be focused (referred to as patient-centered care); 2) the desired health outcomes 
are the clinical goals of the healthcare services being provided; and 3) the current 
professional knowledge that refers to the acquired knowledge and tools that are used to 
support the healthcare providers achieve the clinical goals. To expand the concept of 
quality of care in more detail, the Institute of Medicine illustrates six components of 
quality of care that include safe, timely, effective, efficient, equitable, and patient-
centered as shown in table 1-1 (Institute of Medicine, 2001).  
Component Explanation 




Providing services based on scientific knowledge to all who 
could benefit, and refraining from providing services to those 
unlikely to benefit (avoiding underuse and overuse) 
Patient-centered care Providing care that is respectful of and responsive to individual 
patient preferences, needs, and values and ensuring that patient 
values guide clinical decisions 
Timely Reducing waits and sometimes harmful delays for both those 
who receive and give care 
Efficient Avoiding waste, such as waste of equipment, supplies, ideas, 
and energy 
Equitable Providing care that does not differ in quality because of 
personal characteristics such as gender, ethnicity, geographic 
Table 1-1: Six components of quality of care (Source: Institute of Medicine, 2001) 
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Quality improvement refers to healthcare activities that aim to use current knowledge, 
technology, and available resources to change professional behaviours include critical 
thinking, professional practice, clinical performance, and clinical decision-making to 
increase efficiency; such activities to expand clinical practice to provide a consistent, 
appropriate, patient-focused, and efficient healthcare services to improve outcomes 
(Committee on Quality of Healthcare in America, 2001; Fan, Laupacis, Pronovost, 
Guyatt, & Needham, 2010). The recent increased application of information technology 
in healthcare domain results in an impact to healthcare services not only at an individual 
level, but also impacts aspects of quality of care, organization culture, public relation, 
economy, and healthcare structure (Mainz, 2001). Many numbers of QI initiatives have 
accelerated and become a high priority in the healthcare domain globally as a 
consequence of recent dramatic developments in application of IT in the healthcare, 
healthcare re-organization, and transformation of healthcare systems (Mainz, 2003). 
There have been increased numbers of research studies on QI conducted in healthcare 
organizations during the last two decades; which the focus of these studies was to 
improve the process of caring and healthcare outcomes, increasing patient and employee 
satisfaction, and increase efficiency to improve quality of care (Curtis, Cook, Wall, 
Angus, Bion, Kacmarek, Kane-Gill, Kirchhoff, Levy, Michell, Moreno, Pronovost, & 
Puntillo, 2006; Kaplan, Provost, Froehle, & Margolis, 2012). Although some of them 
have achieved and documented significant improvements in patient outcomes, others 
indicated poor clinical outcomes and research results (Fan, et al, 2010; Kaplan, et al, 
2012). QI is not a simple medical procedure; it is a high level of constructive concept that 
the process includes continuing of thinking, learning, designing, analyzing, implementing, 
evaluating, and reflecting (Kaplan, et al, 2012). There are many factors in relation to 
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individual QI’s objectives, structure, design, process, support, and capacity that influence 
the success of QI according to the individual context of QI and the QI method (Kaplan, et 
al, 2012). To better facilitate Canadian healthcare organizations’ ability to achieve quality 
improvement goals, the Canadian Health Services Research Foundation provides the best 
available evidence to key stakeholders to enable the success in QI by summarizing the six 
QI themes, which are also the six indicators (principles) that are presented in table 1-2 
(Leatherman & Sutherland, 2010). Therefore, understanding the QI objectives and to 
make progress towards the goals for the QI, together with establishing a well-structured 
framework to guide practitioners’ intervention is a crucial component in this QI 
framework to enable achievement in clinical outcomes improvement. 
Quality Domain Principle Examples of measures 
Effectiveness Healthcare services should be based, as 
far as possible, on relevant rigorous 
scientific and research evidence 
1. Mortality rates 
2. Compliance rates with 
evidence-based guideline 
Access Healthcare services should be provided 
at the time they are needed within the 
appropriate settings 
1. Provision of emergency 
care 
2. Availability of specialist 
care or rehabilitation 
Capacity Healthcare systems should be 
sufficiently well resourced to enable 
delivery of appropriate services 
1. Staffing levels 
2. Number of scanners 
3.Information technology 
Safety Patient should not be harmed by the 
care that they receive or exposed to 
unnecessary risk; avoiding injuries to 
patients from care that is intended to 
help them 
1. Nosocomial infections 
2. Medication errors 
3. Falls 
Patient-central  Healthcare should be: 1. Patient evaluations of 
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-based on a partnership between 
practitioners and patients(and where 
appropriate, their families) 
-delivered with compassion, empathy 
and responsiveness to the needs, values 
and preferences of the individual 
patient  
care 
2. Shared decision-making 
3. Patient experiences and 
interactions with staff 
Equity Healthcare should be provided: 
- on the basis of clinical need, 
regardless of personal characteristics 
such as age, gender, race, ethnicity, 
language, socioeconomic status or 
geographical location 
- in such a way to reduce differences in 
health status and outcomes across 
various subgroups 
1. Comparison of care 
provided across different 
sub-populations (for 
example, older people 
versus entire populations0 
2. Mortality rates by 
socioeconomic status 
Table 1-2: Six quality improvement indicators (Source: Leatherman & Sutherland, 2010) 
The remainder of this chapter is structured as follows: in section 1.1, the definition of QI 
and its issues are discussed; section 1.2 briefly describes evaluation of the CDSS and its 
issues; section 1.3 identifies the research motivations; the research aims and objectives 
are discussed in section 1.4; section 1.5 introduces a research method used in this 
research; section 1.6 addresses the research hypothesises; contribution of this thesis will 
be summarized in section 1.7; and section 1.8 presents the thesis overview.   
1.1Quality Improvement and Current Issues 
The concept of QI in the healthcare domain is widespread and has become a high priority 
for healthcare systems globally; it links organizational setting, healthcare delivery 
method, technologies used to support in decision making, clinical practice supported by 
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evidence based practice, collaboration between multidisciplinary professional teams, 
patient and employee satisfaction, and health outcomes (Batalden & Davidoff, 2007; 
Leatherman & Sutherland, 2010; Kaplan, et al, 2012). Batalden and Davidoff defined 
their concept of QI as the combination and effort from everyone involved in healthcare 
delivery activities: patients, healthcare professionals, researchers, payers, planners, and 
educators working together to lead changes to have a better healthcare outcomes (health), 
a better system performance (care), and better professional development (learning) 
(2007). Batalden and Davidoff’s concept of QI emphasized the effort and contribution 
from the collaboration of multidisciplinary teams and composed a big picture of QI at a 
high management level and illustrated an organizational level of structure; however, there 
were insufficient details addressing questions such as: how to structure the QI, what needs 
to be improved in the QI concept, and how to evaluation QI outcomes (Batalden & 
Davidoff, 2007). There are a wide range of QI projects and research studies that have 
been initiated to promote efficiency and quality in acute care settings during the last two 
decades; some of them documented their success in improving clinical outcomes based on 
their contexts (Kaplan, et al, 2012), other studies shown poor QI results and low research 
publication rates due to the lack of framework and structure to guide practitioner 
interventions (Curtis, et al, 2006; Fan, et al, 2010; Leatherman & Sutherland, 2010).  
Because the QI is a complex continual process of thinking, learning, designing, analyzing, 
implementing, evaluating, and reflecting (Kaplan, et al, 2012); factors within the QI that 
are essential include the establishment of goals to achieve the QI objectives; designing a 
structure of QI; monitoring progress; and evaluating the outcomes. Clinical components 
such as mortality, morbidity, health status measurement, length of stay, use of protocols, 
and the role of collaborative team work have been used as success indicators to measure 
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QI outcomes (McMillan & Hyzy, 2007; Mainz, 2003). Although all these indicators 
reflect the QI interventions to some degree in certain circumstances, some of them are too 
general to be measured without clinical guidelines and appropriate interpretation (Curtis, 
et al, 2006; Mainz, 2003). Furthermore, there is a cause-effect relationship between 
structure and outcomes of QI; the process measure based on the scientific evidence also 
plays a key role and needs to be addressed to ensure the quality of QI (Leatherman & 
Sutherland, 2010). However, current issues such as the process of measuring QI remains 
an open research area within the healthcare context, as well as standards for 
measurements of QI are inconsistently described in the literature (Medscape 
Multispecialty, 2007). To be able to better guide professionals to design a QI, Curtis, et 
al. summarized Donabedian’s “structure-process-outcome (SPO)” model which is 
presented in table1-3 (2006). As presented in the table, there is a lack of description and 
explanation of the type of technology used and the number and individual staff roles who 
are involved in the QI process in their model.  
Structure Process Outcomes 
1. Represents the quality of 
care model (the way we 
organize care) 
1. What we do for patient 
and the patient’s family 
1. Morbid event (e.g. 
nosocomial infections, 
venous thromboembolism, 
serious adverse drug event) 
2. How the ICU is 
integrated into the hospital 
or healthcare system 
2. The synchronous efforts 
of a large numbers of 
clinical and nonclinical 
processes 
2. Health-related quality of 
life 
3. Size of unit 3. The important process-
of-care focus for quality 
initiatives is transfer of 
3. Patient and family 
satisfaction of care 
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patients between the ICU 
and other parts of the 
hospital or between 
different clinicians with the 
ICU 
4. Type and amount of 
technology available 
 4. Risk-adjustment mortality 
and standardized mortality 
ratios 
5. The number, roles, and 
responsibility of ICU staff 
 5. Organ dysfunction 
Table 1-3: the Structure-Process-Outcome model (Source: Curtis, et al, 2006) 
1.2 Evaluation of a Clinical Decision Support System and Current Issues 
Garg et al. defined a CDSS as an information system or a computer technique, such as 
software, designed to aid in improving quality of care, safety, and efficiency in healthcare 
(Garg, Adhikari, McDonald, Rosas-Arellano, Devereaux, Beyene, Sam, & Haynes, 2005). 
There are some differences in existing definitions of the CDSS based on the types of 
decisions that need to be made and phases of decisions that need to be supported. For 
instance, various CDSSs focus on checking drug interactions, preventive care alert, 
adverse drug event detection, disease prediction, disease management, cognition support, 
and workflow support (Weber, 2009; Wright, Sitig, Ash, Sharma, Pang, & Middleton, 
2009; Richardson, Ash, Sittig, Bunce, Carpenter, Dykstra, Guappone, McCormack, 
McMullen, Shapiro, Wright, & Middleton, 2010). 
The dramatic innovation of using CDSS to support clinical decision-making in the acute 
care environment is widespread globally. Although IT professionals believed all the 
CDSSs they developed for the healthcare system would have a positive impact on 
improving clinical decision making and outcomes, there are still demands for evaluating 
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the system and desired outcomes because it is not only a cost analysis for implementation, 
but also the effects on further clinical process improvement, clinical performance, and 
quality of care delivered to the public (Gary, et al, 2005). The characteristics of having 
multiple perspectives and types of CDSS have advantages in supporting clinical decision 
making in multidimensional ways to meet many aspects of healthcare demands; the lack 
of universal definition of and consensus of CDSS also has disadvantages in the system 
designing, implementation, and utilization which makes it even more difficult to evaluate 
the effectiveness of the CDSSs (Richardson, et al, 2010). Hunt, et al completed a systemic 
review of evaluating the effectiveness of the clinical support systems for which they 
concluded that the CDSS has a positive impact on physician performance and to improve 
patient care outcomes, however, it contained insufficient discussion on the effectiveness 
of the support for disease diagnosis (Hunt, Haynes, Hanna, & Smith, 1998). The 
limitations of the study, however, were that there was no information provided about how 
the evaluation was completed, which research methods were used, and what were the 
indicators about improved outcomes (Hunt, et al, 1998). Gary, et al also completed a 
systematic review of effects of CDSS for which their results agreed that the CDSS 
improved clinicians’ performance; however, different from Hunt’s study, the effects on 
patient outcomes were understudied and less well described (Gary, et al, 2005).  Another 
review was conducted by Kaplan in 2000; She concluded that the existing issues in the 
demonstration of the effectiveness of clinical decision support systems include the CDSS 
is more equivocal for guideline development and aid physician with diagnosis, there is a 
lack of naturalistic design in routine clinical setting with real patients, and lack of 
demonstration why and how the system were used (Kaplan, 2001).  
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1.3 Research Motivations 
With advances in IT application and biomedical engineering in the acute care 
environment, babies who are admitted in the NICU usually are connected to various 
medical devices to support their life (e.g. a mechanical ventilator) or monitor their clinical 
condition. Modern medical devices have capabilities in acquiring, processing, analyzing, 
and provide limited rolling memory storage of individual physiological parameters such 
as heart rate (HR), respiratory rate (RR), blood pressure (BP), blood oxygen saturation 
(SpO2), and electrocardiogram (ECG) outputs and display them on the screens for 
clinicians to review, to support decision-making about potential diagnoses, and the plan 
of treatment (Blount, Ebling, Eklund, James, McGregor, & Percival, 2010; Catley, Smith, 
McGregor, James, & Eklund, 2010). The data obtained from these medical devices are 
considered crucial and essential in supporting clinical decision making to enable 
clinicians to provide high quality of care and improve clinical outcomes (Griffin, O’Shea, 
Bissonette, Harrell, Lake, & Moorman,  2003; Blount, et al, 2010; Catley, et al, 2010). In 
addition to the advantages that are described above, the innovation of the application of 
IT in the healthcare domain has been designed to take many roles and expand its capacity 
in many aspects of healthcare such as: medical diagnosis, physician order entry, condition 
monitoring, disease management, communication, as well as relationships between 
effective utilization of CDSS and QI outcomes (Weber, 2009). The relationship between 
the QI and the CDSS support is an open research area that causes a motivation to conduct 
this research. Additionally there is a need to better utilize the physiological data collected 
by information systems and medical devices to support QI. The existing issues in the 
current status of QI and CDSS have also motivated this research of discovering how 
CDSS can support QI in the NICU environment. In terms of current states of evaluation 
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of the CDSS, unfortunately there is lack of a definitive model to study the evaluation and 
effectiveness of CDSS, little objective documentation in regards to how CDSS impacts 
clinical practice, and a lack of a standard framework for evaluation of effects and outputs 
of implementation (Rahimi & Vimarlund, 2007). The following issues in the current state 
of QI and CDSS have contributed to motivation of conducting this research study:  
1. There is lack of structure to design QI which reflects relationship about how the 
CDSS to support QI 
2. The traditional health science studies do not take high frequency physiological data 
analysis into consideration when it comes to supporting decision making, because it was 
not possible previously with information technology solution; as a result, there is a lack 
of study on using real-time physiological data to support QI 
3. Most of current QI were conducted at high levels; as a result, the description of QI 
processes in routine practice is under studied 
4. The application of IT in NICU environment requires that obtained clinical information 
should be utilized to enable increased efficiency and improve quality of care, for the 
additional desired outcome of effective support in clinical decision making 
5. There are no methods to investigate whether or not CDSS utilizing physiological 
stream behaviours impacts clinical practice and if so, in what ways 
6. To investigate the impact of CDSS on clinical outcome and decision support 
7. As there is little evidence of reported improvements to date frameworks are required 
that encourage clinicians to adapt to use CDSSs that utilise the behaviour analysis of 
multiple high frequency physiological streams to improve clinical processes and clinical 
practice based on evidence-based practice, to increase value of patient care and 
professional knowledge application  
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1.4 Research Aims and Objectives 
The aims and objectives of this research are to:  
a. To define a QI by using real-time measurable physiological data 
b. To design a framework to support QI in NICU environment 
c. To assess the effectiveness of the CDSS on clinical process improvement and clinical 
outcomes  
d. To demonstrate the framework through a case study in different cultural settings  
1.5 Research Method 
The research method that is used for this study is a constructive research method. 
Constructive research can be described as a case study method that aims to produce 
innovative solutions to solve specific practically and theoretically relevant problems in 
the real world, which results in the creation of new application theory and knowledge and 
to make contributions to the theory of the discipline as presented in figure 1-1 (Kasanen, 
Lukka, & Siitonen, 1993, p. 246). The constructive approach means problem solving 
through the construction of models, diagrams, plans, and organization. The aim of using a 
constructive research model is to “take a real world practical problem and produce a real 












Figure 1-1: Elements of Constructive Research 
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1.6 Research Hypotheses 
A systemic review of existing literature, establishes that there is a relationship between 
physiological data, real-time data analysis, clinical decision support, routine clinical 
practice processes, and quality of care and outcomes improvement. We hypothesize that:  
1. A framework can be defined to enable the QI through implementation of the CDSS in 
the NICU environment 
2. That the framework can be supported by knowledge obtained from analysis of high 
frequency physiological data in real-time  
3. That the framework can be demonstrated to support clinical process improvement  
4. That the framework can be demonstrated within the healthcare setting where clinical 
practice is routinely taken place in different cultural settings 
5. The clinical decision support system can effectively support clinical decision making  
1.7 Scope of Research in the Health Informatics Research Team  
The Health Informatics Research (HIR) team at the University of Ontario Institute of 
Technology is composed of undergraduate students, graduate students, postdoctoral 
fellows and Faculty
1
. Each member of the team has a different research focus that is 
based on the individual’s background and interests. For the Artemis project, the Artemis 
platform was implemented in the NICU at The Hospital for Sick Children, Toronto, in 
August 2009 and in the NICU at The Children’s Hospital of Fudan University in October 
2012. Several research projects have been completed by the team members since the 
implementation of the Artemis system in the two NICUs. Most of these projects were 
focused on real-time data acquisition, processing, analysis and storage; some projects 
focused on parameters such as pain that potentially affect physiological data streams. The 
                                                          
1




area of utilizing real-time data to support clinical decision-making through 
implementation the CDSS had not been studied yet.  
The work presented in this thesis is part of the Artemis Project that mainly focuses on 1) 
supporting clinical decision-making through the implementation of the CDSS; 2) finding 
out whether or not the CDSS will have positive impact on clinical outcomes and clinical 
process thus to improve quality, and 3) using real-time to evaluate the effectiveness of the 
CDSS.  
Limitations also exist in this thesis: 1) This framework design is based on completion of 
validation phase of the Artemis system. Therefore, technological issues such as how to 
handle false alarms; modify the Artemis system to ensure it is compatible with medical 
devices in China have been completed in the previous works or are currently in process; 
ensure the data is acquired and transmitted from China and stored in the HIR Laboratory 
are beyond the scope of this thesis. 2) The focus of this thesis is to design the QI 
framework. Regrettably, due to time restriction, the framework has not been implemented 
in the NICUs yet. As a consequence of awaiting the implementation of the framework, 
data collection, data analysis for validating results, and evaluation of the CDSS are not 
components of this thesis: they are the next steps of the project. 3) Paper documentation 
remains as primary document format in China. There are potential risks of missing 
participants’ original gestational and delivery information in the process of data 
collection, which potentially affects research result when it comes to the point of data 
analysis and generalize research reports. Therefore, the Chinese research partners may 
need to provide an alternative means of documentation for data collection and analysis. In 
addition, some original documents in the Children’s Hospital of Fudan University are 
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written in language other than English. Obtaining technical translation of the documents 
to English may be difficult due to financial constraints, the needs of human assistance is 
an alternative solution.  
1.8 Contribution of this Thesis 
This section discusses the contributions made by this thesis to the development of health 
informatics and QI in NICU 
1. To define a well-structured QI framework to make improvement in clinical practical 
processes using CDSS that improve quality of care which integrates the SPOE, CRISP-
DM, and PaJMa models and enables the processing of high frequency physiological data  
2. Demonstration of using a clinical case within the context of neonatal intensive care  
3. To demonstrate QI can be improved by implementation of the CDSS   
1.9 Thesis Overview 
This thesis is structured as follows: chapter one introduced the research problems, 
research hypothesis, and describes the research methodology used in this study; chapter 
two consists of the literature review of  relevant research questions; chapter three 
describes clinical background in relation to clinical research; chapter four describes 
current neonatal intensive care environment where the research has taken place; chapter 
five presents the framework design; chapter six demonstrates the case study; finally, 




Chapter2: Literature Review 
2.1 Introduction 
The motivations behind this thesis include an increased availability of data in the NICU 
for clinicians to use for clinical decision-making, an increased attention on QI in the 
NICU, to determine whether the CDSS can support QI in cross-cultural NICU 
environment and to evaluate the effectiveness of the CDSS on clinical outcomes and QI. 
This thesis will be demonstrated via a case study in the NICU environment where 
previous research have proved that a changed neonatal condition can be predicted and 
detected by monitoring changes of physiological time series data streams include HR, 
RR, and SpO2 (Griffin; et al, 2003; Blount, et al, 2010; Catley, et al, 2010). This chapter 
is organized into two distinct areas focusing on the context of the research problems:  
 Quality improvement in healthcare, in particular the NICU environment  
 Evaluation of the clinical decision support systems  
2.2 Review Method  
The approach to literature review was divided into two sections based on the two research 
themes: the first section focused on literature related to the quality improvement in the 
NICU and the second section was concerned with work related with the evaluation of the 
CDSS.  The initial search of quality improvement theme began with searching articles 
from the Medline/PubMed, CINAHL, PsycINFO, and Cochrane database for four themes 
consisting of quality improvement in healthcare, neonatal intensive care unit, method of 
quality improvement, and clinical decision support. Boolean result “AND” and “OR” 
were used to specify article keywords; English and Chinese languages were chosen to 
review articles; Articles were selected published from year 2000 to year 2012. The second 
section was seeking literature about the evaluation of the CDSS. Keywords included 
“health informatics interoperability within clinical decision support system”, “real-time 
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data analysis in NICU” “randomized and nonrandomized trials” and “clinical decision 
support system evaluation”. Boolean result “AND” and “OR” were used to specify article 
keywords. Published articles were chosen between the years of 1990 to 2012. In addition 
to above searching technique, review from article reference lists also contributed to article 
searching. An aforementioned technique and a snowballing search techniques also used in 
both sections in conjunction with previous systematic review for the purpose of 
expanding the criteria for additional articles.  
2.3 Review Results  
 Quality improvement theme: the literature search resulted in 3997 screened 
citations, 226 full-text articles were retrieved and of the total 100 met criteria for 
reviewing, among them, more than 20 articles were reviewed to support this 
research.   
 Evaluation of CDSS theme: searched articles for the theme of “evaluation of 
CDSS” as presented in figure 2-1: a total of 213 articles were categorised into four 
sub-groups: cluster randomized trials, controlled before and after studies, and 
interrupted time series designs; among them, more than 15 articles were reviewed 
to support this research. 
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Methods of evaluation of CDSS
N=873
Clinical effectiveness and increase efficiency
N=213
213 studies included:
 Cluster randomized trials
 Nonrandomized trials
 Controlled before and after studies
 Interrupted time series designs
 
Figure 2-1: A total of 213 articles were categorised into four sub-groups 
2.4 Quality Improvement in Healthcare  
QI has been elevated to a high priority globally. The overall goals of QI are to increase 
collaboration within multi professional teams, enhance clinical processes, to improve 
clinical performance, and increase efficiency through means of setting goals, recognizing 
barriers, environmental scanning, examining current clinical processes, identifying gaps 
between current clinical processes and expected clinical outcomes, testing changes in 
these processes, and implementing those changes to improve clinical processes and 
healthcare outcomes (Healthcare providers service organization, 2007; Baker, King, 
MacDonald, & Horbar, 2003). In the past four decades, healthcare organizations have 
been continually seeking strategies and resources to improve quality of care to promote 
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healthcare outcomes while increasing efficiency. To be able to improve quality of care, 
one must first identify an area for improvement and define the concept of QI prior to 
setting a QI initiative. Lohr (1990) defined the quality of care as “the degree to which 
services for individuals and populations increase the likelihood of desired health 
outcomes and are consistent with current professional knowledge” (p.707). In his 
definition, Lohr described different dimensions associated with the term of healthcare in 
his concept: individual, healthcare outcomes, and professional knowledge as presented in 








Figure 2-2: Three themes of quality of care: individual, health outcomes, professional 
knowledge 
Based on the three key components of the concept of quality of care, Batalden and 
Davidoff illustrated the relationships between three components as presented in the  
figure 2-3. Within this figure, Batalden and Davidoff attempted to explain that quality 
improvement is not a simple concept but rather a dynamic process which is affected by 
everyone who is involved in patient’s care, using their best knowledge to promote better 












Figure 2-3: Linked aims of improvement (Reference: Batalden & Davidoff, 2007)
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2.4.1: Overview of QI in Healthcare 
Authors/year 
of published  
Domain Method Structure Intervention Measurement Evaluation 
Scales, et al. 
2011 
ICU A cluster 
randomiz
ed trial 
NO Improve quality by 
implementing multi-





3). Reminders and other 
tools 
4). Audit and feedback 
1. Prevent ventilator-
associated pneumonia 
2. Prophylaxis against 
DVT 
3. Daily spontaneous 
breathing trials 
4. Prevent catheter-
related infection  
5. Early enteral feeding 




1). Process of 
care as indicator 
(improvement) 







NO Improve process by 
conducting staff 
education in particular 
areas: guideline and 
bundles treatment plans 
1. Hospital mortality 
2. Hospital length of stay 
3. ICU mortality 
4. ICU length of stay 
5. Long-term follow up 
with clinical bundle 
A controlled 















issues and changes  
1. Organizational culture 
2. Team work 
3. Leadership  
4. Communication 
No 









2. Habit for change  
1. Multidisciplinary team 
work 
2. Nosocomial infection 
A controlled 






3. Habit for systems 
thinking 
4. Habit for 
collaborative learning  
5. Habit for evidence-
based practice 
3. Chronic lung disease 
4. Intrventricular 
hemorrhage and brain 
injury 
5. Nutrition practice and 
necrotizing enterocolits 
6. Family-centered care 







NO 1. Audit and feedback 
2. Evidence reviews 
3. Training workshop 
4. Ongoing faculty 
support via conference 
calls and email 





Lee, et al. 
2009 





NO Implementing the 
evidence-based practice 
guideline for QI 
method: a) using of 
evidence form 
published literature; b) 
using of data from 
participating hospital to 
identify hospital-
specific practices for 
targeted intervention; 
c). using of a national 
network to share 
expertise 
1. Incidence of 
nosocomial infection  
2. Death and 
bronchopulmonary 
dysplasia 
















NO Using process control 
tool to obtain monthly 
feedback meetings of 
infection rate with SPC 
control charts and 
actions to improve 
infection control further 
1.Hospital wide MRSA 
rate reduction  
A controlled 
before and after 
study 

























management of change 
1. The degree of 
evidence-base practice 
activity over time 
2. The degree to which 
there is evidence that 
individual targeted EBP 
projects’ goals/objectives 
and outcomes were met 
3. Evidence regarding, 
and tracking of change in 
key nursing-sensitive 
outcomes 
4. The degree to which 
there is evidence that 
needed strategic 
department changes per 
EBP-related goals  
5. Evidence of the status 









NO Using process control 
tool (six sigma and 
1. Waiting time A controlled 







statistical process ) to 
control charts for 
surgeon waiting time 
and LOS after colonic 
surgery 
study 













Four steps model:  
1. Summarizing the 
evidence 
2. Identifying barriers 
3. Establishing 
performance measures 
4. Ensuring patients 
receive the intervention 
 
1. Decrease length of 
stay in ICU 
2. Narcotic using  
3. Improved delirium 
status 
A controlled 
before and after 
study 











NO Health information 
exchange  
1. Monitor process 




4. Strength of 
organizational leadership 
in fostering a culture of 
QI 
NO 






Survey NO 1. Quality improvement 
collaborative to 
improve quality by 
increasing 
communication  
2. Pre-intervention and 
1. Patient self-
management  
















Yes 1. Develop leadership 
commitments 




between members  
4. Develop audit and 
feedback process  




confirmed infection rate 
per 1000 central line 
days 
NO 




Many existing systematic literature reviews have explored methods and tools that focus 
on different aspects of QI in healthcare domains. Table 2-1 presented the literature 
reviewed based on the categories of method of QI, structure of QI, means to support QI, 
and evaluation of QI.  
Method of QI: Shaojania and Grimshaw summarized QI strategies that people attempted 
to use as a tool to improve quality. The categories of this method are as follows: 
providing education such as conferences or printed educational materials that detail 
recommendations for management a particular condition; use of reminder systems and 
decision support including adding a sheet on front of a chart alerting providers to date the 
patient’s most recent test results; auditing and feedback to summary of clinical 
performance for individual intervention; patient education to enhance individual patients’ 
knowledge in specific health condition; organizational changes such as changes in 
organizational structure or healthcare team to improve process of care; and financial 
incentives as well as policy to achieve target of level of care (Shaojania & Grimshaw, 
2005).  
Structure of QI: Many QI professionals have realized that existing QI reviews may 
overwhelm clinicians who are interested in QI. Curtis, et al conducted a survey in 2006 
where they summarized and provided a guideline to assist designing the quality 
improvement in the ICU environment. They suggested clinicians use Donabedian’s 
“structure-process-outcome” (SPO) model to first understand the elements and goals of 
quality improvement and then conduct an environmental scan to identify barriers, identify 
measurement variables, before developing and implementing an ICU QI program. 
Although the “structure-process-outcome” model was described as a guide to assist 
27 
 
developing a QI in the intensive care environment, the authors did not describe a specific 
model for clinical process improvement; they also noted they were lacking a method to 
evaluate QI outcomes which is a weakness in their study (Curtis, et al, 2006). 
In the past few years, the PDSA model has been a popular model for QI in the healthcare 
domains. Amount of many articles, Speroff et al discussed how the plan-do-study-act 
model will assist success in quality improvement by increase process of care in detail 
(Speroff & O’Connor, 2004).  
Evaluation of QI: In 2011, Scales et al. implemented a cluster randomized trial QI 
program in fifteen community hospitals in Ontario, Canada with goals of using evidence-
based practices to improve ICU care outcomes and to determine the effectiveness of a 
multicenter QI program to increase care delivery (Scales et al, 2011). As a result of their 
study they concluded that a multi-intervention improved adoption of care practices. 
However, the limitations of study were failing to include a clinical process model, and a 
lack of documented processes of care (Scales et al, 2011).   
Through the above systematic review of existing literature, it is notable that there are a 
few characteristics in current state of quality improvement in the intensive care 
environment: quality improvement in the intensive care environment has started to get 
much more attention than ever before. As a consequence, studies on quality improvement 
may overwhelm clinicians who are interested in quality improvement and have to 
critically analyze current state and literatures of QI. Problems with a current state of 
quality improvement includes issues such as a lack of descriptions of QI processes in 
detail when conducting a QI; there is an increased attention on using a randomized 
control study design for quality improvement research; using real-time data to improve 
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quality is still under-utilized; and the needs of attention on evaluating the effectiveness of 
QI program is essential.  
2.5 Overview Evaluation of a Clinical Decision Support System 
CDSSs are computer systems and/or software that support clinician decision-making 
(Berner & Lande, 2003). Although the CDSS has been used widely in the healthcare 
domain and has played as an essential role in assisting clinician decision making during 
the process of care, evaluation the effectiveness of CDSS remains a challenge due to lack 
of a consensus of CDSS definition, in addition to the nature complexity of the CDSS 
(Sintchenko, Magrabi, & Tipper, 2007; Rahimi &Vimarlund, 2007); therefore, by 
understanding the CDSS in the healthcare domain will assist to evaluate effectiveness of 
CDSS in clinical outcomes.  
2.5.1 Understanding the using of CDSS to support quality improvement  
The concept of a clinical decision support system was evolved from the concept of 
decision support system (DSS), as Marakas defines  
A decision support system is a system under the control of one or more decision 
makers that assist in the activity of decision making by providing an organized set 
of tools intended to impose structure on portions of the decision-making situation 
and to improve the ultimate effective of the decision outcome (Marakas, 2003, p.4) 
The CDSS then is defined as a designed decision support system(DSS) that aims to assist 
clinicians’ decision-making in the clinical setting (Berner & Lande, 2003). There are two 
types of CDSS in general. This includes the knowledge-based system that applies rules to 
patient data by using an inference engine and displays the results to the end user and the 
nonknowledge-based system that relies on machine learning to analyze clinical data to 
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assist decision-making based on learning. Examples and features of the two types of 
CDSS are presented in table 2-2:  
 Types of clinical decision support system 
 Knowledge-based clinical 
decision support system 
Non knowledge-based clinical 
decision support system 
Example - Diagnostic decision support 
system 
- Clinical order entry system  
- Also namely artificial intelligence 
system 
- Artificial neural networks (ANN) 
Feature - Provide information rather than 
analysis of information  
- Does not simulate an expert’s 
decision making 
- Clinician make their own 
decision based on the information 
provided by the system 
- Learn from previous experience  
- Simulate human thinking  
- Analysis of patterns in the data 
(training the artificial network) 
- Assist clinician decision making in 
real-time data  
- Make prediction based on data  
Components 
of the CDSS 
Three parts: 
- Knowledge base 
- Inference (reasoning engine) 
- Mechanism for communication  
Five parts: 
- The data management system 
- The model management system 
- The knowledge engine 
- The user interface 
- The user 
Table 2-2: Type of clinical decision support system (Source: Berner & Lande, 2003) 
 
2.5.2 Review of evaluation of CDSS 
There are many publications that have demonstrated that the use of CDSS has led to 
positive impacts on clinical outcomes and in reducing total cost of care (Berner & Lande, 
2003). Several literature articles focused on how to and what to evaluate the CDSS are 
well documented by scholars, some of which are summarized in table 2-3:
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Metrics used to evaluate 
the system 
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of the health 
information 
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4) Data protection is 
adequate 
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of decision making 
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audit or research 
 





effects of CDSS, 




 CDSS Randomized and 
nonrandomized 
controlled trial   



























a CHSS may 
or may not 
be effective 
Sim, et al. 
2001 















CDSS use and 
design.  
The use of CDSSs to 
facilitate evidence-based 
medicine therefore 
promises to substantially 
improve healthcare 
quality 



























To evaluate of a 









CDS A randomized 
controlled trial 
1. Clinical decision 
support 
2. To test the impact of 
the tools –analysis of 
bone mineral density 
1. The 
instrumentati






3. To measure treatment 
result 

















To evaluate how 
well EPR system 
meet the needs of 
physician and 
other professional  
To determine if 

















Through a systematic review of evaluation of the CDSS, there are a few issues that 
remain as challenges and need more attention:  
1). As the overall goal of the application of IT in the healthcare domain, up-to-date, there 
is lack of a standard and structured framework for evaluation of the effectiveness and 
output of implementation in the healthcare, as well as lack of research which focuses on 
and explores the impact of IT on the healthcare system’s productivity and effectiveness 
(Littlejohns, et al, 2003; Rahimi & Vimarlund, 2007). It is noted that a needs of a 
structure of evaluation method for the objectively evaluate the effectiveness of IT is 
essential and urgent. 
2). Liu and Wyatt conducted a randomized controlled trial in 2010, they commented that 
the randomized controlled trials have become a gold standard for clinical research in 
pharmacy, clinical outcomes measured; however, randomized controlled trials (RCT) 
have a limited role in evaluating clinical information system due to the nature of research 
design and the complexity of clinical sittings (Liu & Wyatt, 2011). They pointed out the 
limited role of RCT in evaluating clinical information system, causes and needs, outline 
challenges and potential alternations solutions of use RCT in the evaluating clinical 
information system. 
3). Many studies involved field tests of a CDSS using different methods but there is lack 
of naturalistic study design in routine clinical settings with real-patients (Kaplan, 2001). 
In addition, the CDSS has been evaluated as stand-alone system, and was therefore not 
integrated into the clinical information system (Aronsky, 2001).  
4). Their studies indicated factors that contribute to successful CDSS implementation 
including providing alert, suggestion, and computerizing the entire process (Berner & 
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Lande, 2003); how to (method) evaluate the CDSS remains under study (Wyatt et al, 
2003).  
5). Research mostly focuses on clinicians’ performance measure and practice guideline 
improvement, but was inconsistent and inconclusive on patient outcomes due to lack of 
data (Sintchenko, et al, 2007).  
6). There are limited studies on using physiological data as effectiveness variables to 
evaluate a CDSS, which provides research an area for future study  
7). There are also limited studies on relationship between CDSS to support QI, which 
open a new research area for researchers   
2.6 Implication and Impact on this research 
The result of above literature review exemplifies the motivation for a structural QI 
framework supported by the clinical decision support system in cross-cultural NICU 
environment and evaluation of the clinical decision support system. The overview of 
existing QI from section 2.3 has shown the desired outcomes of having QI framework to 
enable researchers to reach goals of quality improvement. Moreover, to determine 
whether or not the clinical decision support system is effectively support QI, the needs of 
using realistic and measureable variables are the keys. This leads to the formulation of 
hypothesis 5 of the thesis: the clinical decision support system can effectively support 
clinical decision-making.  
2.7 Summary  
This chapter has presented a systematic literature review associated with the context of 
the research problems addressed in chapter 1. While there have been increased efforts on 
increasing utilization of physiological data to support clinical decision making, it has led 
to an opportunity to conduct this research. Since the CDSS has been used as a tool to 
35 
 
support QI, whether or not the CDSS impact on clinical outcome and in which degree 
provides another opportunity for clinical research.  
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Chapter 3: Background 
Different from a simple procedure, quality improvement is a complex continuing dynamic 
process with many factors involved in order to achieve success in quality improvement in 
the healthcare field. The intent of this research is to design a conceptual framework for QI 
initiatives in the NICU environment by utilizing physiological data in real-time in 
combination with the CRISP-DM and the PaJMa models. The following sections discuss 
individual background components that relate to this research in detail. They include 
information about the CRISP-DM methodology, the PaJMa model, the Artemis clinical 
decision making support system, and previous research outcomes across these areas that 
formed foundational work in support of this research.  
3.1 The CRISP-DM Methodology  
The Cross Industry Standard Process for Data Ming methodology (CRISP-DM) was 
developed in 1990’s as a model of the data mining process (Chapman, Clinton, Kerber, 
Khabaza, Reinartz, Shearer, & Wirth, 2000).  
 
Figure 3-1: The phases of the CRISP-DM reference model (Chapman et al, 2000) 
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As shown in figure 3-1, the model breaks down a data mining life cycle into six phases: 
(1) business understanding 
(2) data understanding 
(3) data preparation 
(4) modeling 
(5) evaluation 
(6) deployment  
The CRISP-DM methodology has been widely used and has become a standard model for 
data mining and knowledge discovery in many industry sectors, but has only been applied 
limitedly in the healthcare domain (McGregor, Catley & James, 2012). In particular it 
lacked provisions for multi-dimensional time series data mining (Catley, Smith, 
McGregor & Tracy, 2009). 
In the early 2000s, McGregor and her team began to apply the CRISP-DM model in the 
field of health informatics and have made some significant achievements in the past few 
years. The concept of data process mining was first introduced and demonstrated by 
Heath and McGregor. To validate the suitability of the CRISP-DM model in healthcare 
domain, Heath (2006) in her Master’s thesis demonstrated the CRISP-DM model’s 
correlation with the scientific method showing that it can be suitable in medical research 




Figure 3-2: Parallelism between CRISP-DM and the Scientific Method (Heath, 2006) 
In 2009, McGregor et al. first introduced the CRISP-DM principle in the critical care area 
by extending it to create the CRISP-TDM model. The focus of this new model was to 
process multidimensional physiological data streams and demonstrated its relevance for 
clinical research through a case study of earlier detection of late onset neonatal sepsis in 
the NICU environment as presented in appendix 1 (McGregor, et al, 2010). In this 
research, McGregor, et al. utilized the CRISP-TDM model to develop a framework for 
temporal data mining particularly focused on multi-dimensional time series data mining 
in the NICU environment. They concluded that the CRISP-TDM model was a successful 
approach to knowledge discovery from multi-physiological data together with complex 
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real-time data analysis, which demonstrated that the CDSS has its capacity in supporting 
clinical decision making (McGregor, et al., 2010).  
McGregor et al. late on applied the CRISP-DM principle in the area of critical care area 
where they developed and designed a framework for clinical guideline improvement in 
critical care environment that was demonstrated with a neonatal apnoea case study 
(2012). In this particular research, McGregor and her colleagues not only focused on 
extending the capacity of CRISP-DM in the critical care arena, but also discovered the 
relationship between patient journey modelling (PaJMa) and process mining in critical 
care components as shown in figure 3-3 (McGregor, et al, 2012). The evolution of 
introducing the newly developed concept of PaJMa into process mining has significant 
impact on their later researches, which also funded the concept of this research, moving 
the concept of guideline improvement forward in the area of QI in NICU (McGregor, et 




Figure 3-3: Relationship between PaJMa layers and process mining in critical care 
components (McGregor, et al, 2012) 
The results from this clinical research have made a significant contribution in data 
process mining, especially with the multi-dimensional time-series data process mining in 
real-time to support clinical decision making, as well as providing a scientific base for 
this research.  
3.2 Patient Journey Model Architecture 
The Patient Journey Modelling Architecture (PaJMa) was designed specifically for 
healthcare environment by McGregor et al in early 2000s (Percival, Catley, McGregor & 
James, 2009). The PaJMa model provides a visual representation of related business 
processes, data and information flow, technology and clinical guidelines that involved in 
a patient journey in different clinical settings, individual professional roles in the process 
of patient care, and timing spent on each clinical step (Percival, et al, 2009). It also “uses 
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horizontal lays to present independent information on different aspects of the patient’s 
journey which lays are read vertically from left to right, with each process step moving 
across the page”  (Percival, et al, 2009. P.7.). 
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Figure 3-4: Patient Journey Model Architecture (PaJMa) 
As Percival described in her article, the PaJMa shown in figure 3-4, working from the 
top-down, each layer provides important information related to the patient journey:  
“(1) a patient’s entry into the healthcare journey and consecutive interactions 
with staff 
(2) staff roles, technologies, and processes within in the journey 
(3) the individual roles involved in each step during the patient’s journey that 
provides the concept of patient-centre care; processes and possible decisions 
made that comprise the clinical interventions and action of the journey 
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(4) the information required, obtained, and flowed by each process 
(5) the technology involved in each step and underlying infrastructure support 
(6) the patient’s care needs and priorities are also presented in the diagram 
(7)the policies and clinical guidelines support each decision making; the 
presentation of optional metrics in each step is an unique feature the PaJMa 
model ”(Percival, et al, 2009. P.7).  
3.2.2 PaJMa and Process Improvement  
As an increased effort on improving clinical processes to increase outcomes and QI, 
various process improvement methods that have been created and applied in the area of 
QI are well documented: the using of the basic flowchart, process mapping and PDSA 
rapid cycle, and the cognitive workflow map, et al (Jun, Ward, Morris & Clarkson, 2009; 
Wall, Ely, Dlasy, Dittus, Forr, Wilkerson & Speroff, 2005; Malhotra, Jordan, Shortliffe, 
& Patel, 2007). Jun et al (2009) identified that systematic understanding of care processes 
is a necessary step to “effective quality improvement”. They designed a process model 
called “two-fold” and aimed to improve quality which they described first step is to 
improve understanding and the second step is the documentation of a plan of QI in order 
to identify areas for improvement. Although they described eight modeling techniques 
that they used, they argued that the basic flowchart was unnecessarily complex. The key 
point of their model was understanding and documentation (Jun, et al, 2009).  
Wall et al described a quality improvement initiative to reduce catheter-related 
bloodstream infection from central venous catheters in an ICU. By applying the technique 
of process mapping and the Plan-Do-Study-Act (PDSA) cycle in the unit, they were able 
to reduce the total number of infection cases as a result of embedding the process flow 
measures within the documentation system (2005). 
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In the other study, a complex workflow map was developed for the ICU environment for 
the purpose of identifying causes of medical errors and medication error prevention by 
Malhotra, et al. (2007). As a consequence of their study, the underlying cause of medical 
errors was able to be discovered to alert clinicians, however, the workflow map was very 
complex and also lack of provision of process of care provision.  
The PaJMa model has been used in clinical settings in the last few years. Recent studies 
have indicated that PaJMa is effective modeling in playing different healthcare roles and 
associated process, has positive impact on caring process, and it able to represent the use 
of technology to support the process (Percival, et al, 2009). However, to date, PaJMa has 
not been used to support the events based activities that constitute clinical guideline 
models, where responses to events can trigger ad hoc pathways of patient journey 
(Percival et al, 2009). In this research, PaJMa modeling will be integrated with the new 
designed model to support QI by smoothing the patient journey process.  
3.3 The Clinical Decision Support System  
A CDSS refers to an information technology application system used to support clinicians 
in making clinical decision. The literature review chapter has described different types of 
the CDSS, including Artemis, an intelligent data analytical system that was designed to 
provide a real-time data processing environment in supporting the intensive care 
environment for clinical research (Blount, et al, 2010).  
3.3.1 The CDSS Architecture 




Figure 3-5: The Artemis System Architecture (Blount, et al, 2010) 
As presented in figure 3-5, there are a few key components in the Artemis system: The 
Medical Data Hub is responsible for collecting existing data from various medical 
devices; the IBM’s InfoSphere Steams software plays an important role in real-time steam 
processing with capacity in handling multiple steams of high volume and high rate data; 
an Clinical Information System(CIS) Adapter assists in accessing an individual patient’s 
data from the CIS which is integrated in the Artemis system; and Data Integration 
Manager (DIM) server acts as a bridge between the streaming application as well data 
transmission in related database in different locations which allow data transmitted from 
different locations to the data centre for purposes of data storage and analysis (Blount, et 
al, 2010). As a consequence of the technique design, the Artemis system supports the 
capture of acquisition, collection, storage, transmission, and processing of multiple high 
frequency physiological data streams in real-time, perform data mining, and retrospective 
analysis of wave and numeric form of data streams combined with the supporting clinical 
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information management system (CIMS) and the laboratory information system (LIS) 
(Blount, et al, 2010; McGregor, et al, 2011).  
3.3.2 Implementation of the Artemis in NICU environment  
Since 2009, the Artemis system has been deployed in several NICUs in different hospitals 
and is able to acquire, collect, analyze, and store data containing electrocardiogram 
(ECG), heart rate (HR), respiratory rate (RR), and oxygen saturation (SpO2) and blood 
pressure (BP) streams as well as CIMS observations for clinical research (Blount, et al, 
2010).  
 
Figure 3-6: Overview of integration of Artemis system (Blount, et al, 2010) 
For example, Catley et al had developed a framework for modeling and translating 
clinical rules to support complex real-time analysis of physiological and clinical data 
through the Artemis system support in figure 3-7 (Catley, et al, 2010). Their research 
demonstrated the Artemis analytic system has capacity in identifying and detecting data 
patterns in physiological data streams when indicative onset of clinically significant 




Figure 3-7: SaO2 values against a threshold of 85 and ABP mean values against a 
threshold of 35 (Catley, et al, 2010) 
 Recently, by discovering and recognizing while the Artemis system has the capacity in 
detecting heart rate variability in premature infants to assist clinician decision making to 
identify late onset sepsis, the Artemis system sometimes also targets false alarms due to 
special medical circumstances such as postoperative status, suctioning, and usage of 
narcotics (McGregor, eal al, 2010). McGregor and her collogues designed and prototyped 
an artifact management and an artifact alert integration system to capture artifact event 
thus to minimized false alarm to increase the system’s accuracy as presented in figure 3-8 





Figure 3-8: The capacity of the CDSS in identify HRV/RRV pattern for narcotics 
followed by Surgery + Narcotics (McGregor, et al., 2012) 
The successful implementation of the CDSS in acute clinical settings and previous 
clinical research demonstrates that the CDSS has capacity in analysing high-frequency 
physiological data streams according to clinical rules to support clinical decision making 
which provided scientific evidence for further utilizing the CDSS as a platform to 
perform this research.  
3.4 Summary  
This chapter has provided background information relevant to this research. The first 
section provides an introduction and description of the CRISP-DM methodology, the 
application of the CRISP-DM in data mining, and utilization in health informatics field. 
The section presents the PaJMa model and recent studies of PaJMa to support process 
improvement, as well as new clinical process approach PaJMa and its potential capacity 
in QI. The last section discussed the CDSS that used in this research and it capacity in 
early detection of sepsis related conditions; to present how this research will be supported 
by the existing evidence based medicine practice and scientific evidence for the capacity 
of the CDSS.  
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Chapter4: The Neonatal Intensive Care Environment 
4.1 Introduction  
This chapter presents a review of the neonatal intensive care units in Canada and China. 
A full-term baby refers to a baby who was born between 37 completed weeks of 
gestational age to 42 weeks of gestation (World Health Organization [WHO], 1977). 
Most infants who are delivered from 37 weeks of gestation completed to 42 weeks of 
gestation can be discharged from hospitals when they are two or three days old. Whereas 
other babies who are born less than 37 weeks gestation are referred to as “preterm infant”. 
Under the large umbrella of preterm birth, preterm birth is also categorized into three sub-
groups based on gestational age (Media centre, WHO, May 2012):  
 Extremely preterm (<28 weeks) 
 Very preterm (28 weeks to <32 weeks) 
 Moderate to late preterm (32 weeks to 37 weeks) 
As they are not mature enough, the preterm and low birth weight babies are major 
challenges for perinatal and neonatal care because their under developed and immature 
body systems attribute to their inability to adept to the natural living environment after 
they are born. As a consequence, the preterm and low birth babies have longer length of 
stay, higher mortality, and morbidity rates when compared with full term babies 
(Canadian Institute for Health Information [CIHI], 2009). They are clinically unstable, 
and are at high risk of developing a range of poor neonatal outcomes such as: respiratory 
distress syndrome, gastrointestinal complication, infection, as well as having series 
problems in their later life such as learning disability and development or behavioural 
issues (CIHI, 2009). They will not be discharged from hospitals until they are clinical 
49 
 
stable. Figure 4-1 present information about gestational age at birth and survival 
discharge from participating NICUs in Canada in 2010.  
 
Figure 4-1: Gestational age at birth and survival to discharge from NICUs (CNN, 2010) 
As shown in the above graphs and table, for the group of preterm and low birth weight 
infants, there is obviously a trend that indicates the closer to a full term, the higher 
infants’ survival rate. The concept of a neonatal intensive care unit (NICU) therefore was 
designed and built to provide quality of care to ensure survival of preterm babies 
(Committee of Fetus and Newborn, 2004). A NICU is a dynamic healthcare professional 
team with advanced technology assistance to facilitate optimal outcomes and is an 
essential key to providing care to high-risk infants including those born preterm or with 
serious medical/surgical condition to improve outcomes (Committee on Fetus and 
Newborn, 2004). 
The remainder of this chapter describes the context of NICU environment in Canada and 
in China. The chapter is structured as follows: section 4.2 describes the NICU context, 
physical environment, medical devices and monitors in Canadian NICU; section 4.3 
describes the NICU in China, including detailed information about NICU context, 
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physical environment, and medical devices and monitors; section 4.4 briefly describes 
issues of neonatal sepsis, its complication, challenges clinicians are facing with diagnosis, 
and needs of better management to prevent this condition.  
4.2 Neonatal Intensive Care in Canada 
4.2.1. NICU Canadian Context 
There are approximately 13 million premature babies born each year globally. In North 
America, approximately 10 per cent of newborns, or 500,000 babies, are preterm infants 
according to CBC news (CBC News October 4, 2009). A recent report from the CIHI 
indicated there were more than 54,000 preterm babies or low birth weight for their 
gestational age (GA) born in Canada in the year of 2009.  
Infants admitted into the NICUs range from as small as less than 23 weeks of gestation to 
greater than 42 weeks of gestation (CNN, 2010). All these infants in NICUs need constant 
attention and monitoring for their condition based on individual infants’ complexity of 
care needs. To be able to meet their care needs, the neonatal intensive care unit is 
organized into three designations at hospitals in Canada according to the Fetus and 
Newborn Committee in the Canadian Paediatric Society (CPS, 2004):  
Level 1: Basic neonatal care (normal newborn nursery) 
Level 1a:   
• Evaluation and postnatal care of healthy newborn infants; and 
• Phototherapy 
Level 1b: 
• Care for infants with corrected gestational age greater than 34 weeks or weight 
greater than 1800 g who have mild illness expected to resolve quickly or who are 
convalescing after intensive care;  
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• Ability to initiate and maintain intravenous access and medications;  
• Gavage feeding; and  
• Nasal oxygen with oxygen saturation monitoring (eg, for infants with chronic 
lung disease needing long-term oxygen and monitoring) 
Level 2: High-dependency neonatal care (special care newborn nursery) 
Level 2a:  
• Care of infants with a corrected gestational age of 32 weeks or greater or a 
weight of 1500 g or greater who are moderately ill with problems expected to 
resolve quickly or who are convalescing after intensive care; 
• Peripheral intravenous infusions and possibly parenteral nutrition for a limited 
duration; 
• Resuscitation and stabilization of ill infants before transfer to an appropriate care 
facility; and  
• Nasal oxygen with oxygen saturation monitoring (eg, for infants with chronic 
lung disease needing long-term oxygen and monitoring) 
Level 2 b:  
• Mechanical ventilation for brief duration (less than 24 h) or continuous   positive 
airway pressure; and 
• Intravenous infusion, total parenteral nutrition, and possibly the use of umbilical 
central lines and percutaneous intravenous central lines 
Level 3: Intensive neonatal care (neonatal intensive care nursery) 
Level 3a:  
• Care of infants of all gestational ages and weights; 
52 
 
• Mechanical ventilation support, and possibly inhaled nitric oxide, for as long as 
required; and  
• Immediate access to the full range of subspecialty consultants 
Level 3b: 
• Comprehensive on-site access to subspecialty consultants; 
• Performance and interpretation of advanced imaging tests, including computed 
tomography, magnetic resonance imaging and cardiac echocardiography on an 
urgent basis; and  
• Performance of major surgery on site but not extracorporeal membrane 
oxygenation, hemofiltration and hemodialysis, or surgical repair of serious 
congenital cardiac malformations that require cardiopulmonary bypass 
Level 3c:  
• Extracorporeal membrane oxygenation, hemofiltration and hemodialysis or 
surgical repair of serious congenital cardiac malformations that require a 
cardiopulmonary bypass (CPS, 2004) 
4.2.2 The NICU Environment in Canada 
With rapid information technology application in acute care environment, new techniques 
and instruments play important roles in life support, monitoring, and treating sick babies. 
Neonates soon after birth are connected with various medical devices to monitor their 
condition and even to provide life support after admission is routine practice in most of 
level III NICUs.  
Through the medical devices and adequate hospital information system, the babies’ 
physiological data such as HR, RR, electrocardiogram, peripheral oxygen saturation, and 
blood pressure can be captured and constantly displayed on screens for clinicians to 
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review (Figure 4-2); however, in the current practice model, most of these data are 
snapshots on screens for clinicians review unless they document the data on paper for 
further use. This practice model has limitation in assist clinical decision making because 
of its inefficacy (clinicians have to manually document data on paper), inconsistence of 
data analysis, and not real-time data.    
 
Figure 4-2:  The NICU environment in Canada (Source: Kamaleswaran, 2011) 
As one of the goals of this research is to improve current clinical practice, with 
implementation of the CDSS in this research, the availability and storage of neonatal 
physiological data in the clinical system usually as an hourly spot or summary reading, 
which provides health informatics professionals a great opportunity to utilize the data to 




4.2.3 The Medical Devices and Monitoring in the NICU in Canadian Context 
 
Figure 4-3: Medical devices used in Canadian NICU (Source: Kamaleswaran, 2011) 
As displayed in figure 4-3, in order to closely monitor a neonate’s condition; all neonates 
who stay in the NICU are connected with various medical devices to have life support 
and condition monitoring. Such equipment includes: 
 Overhead warmer: an overhead warmer is a heating source that provides heat to a 
baby. A warmer usually used instead of an incubator if the baby needs to be 
handled frequently.  
 Phototherapy lights: the bright blue fluorescent lights placed over the baby’s 
incubator are used to treat jaundice. Babies with jaundice usually receive the 
“phototherapy” treatment for about one week based on doctor’s order.  
 Blood pressure monitor: a blood pressure monitor is a machine connected to a 
small blood pressure cuff wrapped around a baby’s arm or leg. The cuff 
automatically takes the baby’s blood pressure at regular time and displays the 
numbers on a screen for clinician to read.  
55 
 
 Cardiopulmonary monitor: a machine that tracks the baby's heart and breathing 
rates. It is connected to the baby by small adhesive monitoring pads placed on her 
chest. The monitor displays information on the screen, which can be printed onto 
paper. If the baby's heart or breathing rate becomes too fast or too slow, an alarm 
will sound.  
 IV pump: a doctor or nurse will insert a very small needle or tube into a tiny vein 
in the baby's hand, foot, arm, leg or scalp. The needle is taped in place, and 
attached to a thin plastic tube (IV line). The tube goes to an IV pump connected to 
a pole next to the baby's bed. The baby can also receive medications and blood 
through the IV line.  
 Umbilical artery catheter: a baby's umbilical cord has two arteries and one vein, 
which end in his belly button. A thin tube (catheter) can be inserted into one of 
these vessels and threaded to the aorta, the largest artery supplying oxygen to the 
body. Through this catheter, doctors and nurses can painlessly draw blood. They 
don't have to repeatedly stick the baby with needles. They can give him fluids, 
blood, nutrients and medications through this tube. A small device can be attached 
to the catheter to continuously monitor the baby's blood pressure. 
 Oxygen saturation monitor: a small U-shaped device that is wrapped around a 
baby's foot or hand and secured with a stretchy bandage. It uses a light sensor to 
help determine if the baby has enough oxygen in her blood. This sensor does not 
hurt a baby at all. It helps doctors and nurses determine whether she needs more or 
less oxygen, while reducing the need for painful blood tests. 
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 Feeding tube: a medical device used to provide nutrition to neonate who cannot 
obtain nutrition orally.  
 Ventilator: a mechanical ventilator is a breathing machine that delivers warmed 
and humidified air to a baby's lungs. The sickest babies receive mechanical 
ventilation, meaning that the mechanical ventilator temporarily breathes for them 
while their lungs recover. The air is delivered to the baby's lungs through an 
endotracheal tube (a small plastic tube that is inserted through a baby's nose or 
mouth down into the windpipe). The amount of oxygen, air pressure and number 
of breaths per minute can be regulated to meet each baby's needs. (March of 
Dimes, 2012).  
4.3 The Neonatal Intensive Care in China 
4.3.1 NICU Chinese Context 
According to statistics from the WHO report in May 2012, there are about 1,172,300 
preterm babies born in China each year (WHO, 2012).  
There are three levels of hospitals in China according to the official standards including 
financial state, annual budgeting, total beds of hospital, and medical equipment; however, 
the levels of neonatal care provision in a hospital is not clearly identified and categorized 
due to complicated historical and political reasons (Feng, 2009). According to Feng, in an 
urban area, some hospitals are able to provide care to babies whose care is complex, 
while others are not. The hospitals that are able to provide quality of NICU services with 
modern medical devices are mostly located in big cities such as Shanghai and Beijing; 
others hospitals may provide level II NICU services in mid-size cities (Feng, 2009). 
Recently, following the American Academy of Pediatrics (AAP) standards, the Ministry 
of Health of China created “A guideline to build a NICU in China” with the purpose of 
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attempting to categorize neonatal intensive care units. Listed below are the described 
requirements in details:  
Level I: Normal newborn nursery where provides basic neonatal care  
 Neonatal resuscitation 
 Healthy baby evaluation and postnatal care of healthy newborns  
 Care for infants with slight deformity and high risk full term newborn with stable 
vital sign  
 Initiative treatment and monitor those neonates who require to transfer to a NICU  
Level II: (Neonate Special Care Unit) 
Level II A: 
 Care for infants whose vital sign stable pending to transfer to NICU for other 
diseases 
 Care of infants with gestation ≥32 weeks or greater or has a birth weight of 1500 
g or greater who are moderately ill with problems expected to resolve quickly or 
who are convalescing after intensive care 
 Able to care of infant birth weight 2000 g or greater or gestation 35 weeks or 
greater 
 Apgar 4-6 with stable vital signs 
 Intravenous infusion, total parenteral nutrition, and possibly the use of umbilical 
central lines and percutaneous intravenous central lines 
Level II B:  
 Need 24 hours ventilation or continuous positive airway pressure (CPAP) 
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 Care of infants whose birth weight 1500 g or greater, or gestation 32 weeks or 
greater 
 Less than 72 CPAP or less than 24 hours ventilation 
 Onsite ultrasound   
 Intravenous infusion, total parenteral nutrition, and possibly the use of umbilical 
central lines and percutaneous intravenous central line 
Level III: (Neonatal Intensive Care Unit)  
 Care of infants of all gestational ages and weights; 
 Constantly RR, HR, HP, blood gas, electronic monitoring 
 Mechanical ventilation support 
 ECG, CT and MRI 
Level III A:  
 Care of infants birth weight 1000 g or greater or gestation of age 28 weeks or 
greater 
 Severe sepsis 
 Mechanical ventilation support  
 Minimal deformity correction surgery 
Level III B: 
 Care of infants birth weight less than 1000 g or gestational age less than 28 weeks, 
need advance NICU care  
 Comprehensive on-site access to subspecialty consultants; 
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 Performance and interpretation of advanced imaging tests, including computed 
tomography, magnetic resonance imaging and cardiac echocardiography on an 
urgent basis; and  
 Performance of major surgery on site but not extracorporeal membrane 
oxygenation, hemofiltration and hemodialysis, or surgical repair of serious 
congenital cardiac malformations that require cardiopulmonary bypass 
Level III C: 
 Able to perform extracorporeal membrane oxygenation, hemofiltration and 
hemodialysis or surgical repair of serious congenital cardiac malformations that 
require a cardiopulmonary bypass (The Ministry of Health of China, 2012: 
Building NICU guidelines) 
4.3.2 The Medical Devices and Monitoring in the NICU in Chinese Context 
 
Figure 4-4: NICU Medical Monitoring Devices in China (Photo taken on Aug 26, 2011 at 
The Children’s Hospital of Fudan University, Shanghai, China) 
There are some similarities in level III NICUs in Canada and China in regards to the 
medical devices used in the NICUs, such as using an overhead warmer, billirubin lights, 
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umbilical artery catheter. However, there are some main differences between Canadian 
and Chinese NICU’s as a consequence of policy: 
1). Canadians do not have to pay any healthcare cost if they are hospitalized as a benefit 
from the public healthcare system whereas Chinese have to pay all hospital cost if a 
resident does not have fully instance coverage;  
2). In China, clinicians use pulse rate that is derived from pulse oximetry to monitor 
cardiac function instead of using the ECG as part of routine practice;  
3). Chinese clinicians tend to feed a baby with an oral syringe instead of a feeding tube 
as well as tend not to use an IV pump in the NICU 
4). the biggest practical different between Chinese and Canadian clinicians are Chinese 
clinician  do not offer any infant narcotics such as morphine for pain management as per 
their cultural believes and values while the Canadian infant will receive narcotics if it is 
necessary for the infants to have better pain management 
All these differences in clinical routine practice have impact on the quality of care 
clinicians provide to infants; therefore, these factors have to be taken into consideration 
when designing the framework for QI to ensure the framework can be implemented in 
different cultural settings.  
4.4 Neonatal Sepsis 
Neonatal sepsis is a complex medical condition that remains a major cause of morbidity 
and mortality in children worldwide, with an especially high prevalence in low birth 
weight (LBW) and premature infants as shown in figure 4-5 (Goldstein, Giroir & 




Figure 4-5: Prevalence of late-onset neonatal sepsis by birth weight (CNN, 2010) 
Clinically, neonatal sepsis is usually described as a symptom rather than a disease and is 
categorized into two subgroups according to time to onset of clinical signs and symptoms. 
Early-onset sepsis usually occurs within the first 72 hours of neonatal life and late onset 
sepsis (LONS) occurs after 72 hours to 9 days of life (Ng, 2003; Vergnano, Sharland, 
Kazembe, Mwansambo, & Health, 2004). Clinical studies have found while early-onset 
sepsis mainly is caused by acquiring the infection agent prior to and/or during the process 
of delivering, late-onset sepsis is caused by acquiring the infection agent after infants 
were born (Vergnano, et al, 2004). Any delay in and/or inability to diagnose and 
commence treatment of sepsis can lead to severe complications, such as impaired 
neurologic function, cerebral palsy, intravascular coagulation, septicaemia shock, and 
death (Carcillo, 2005; Ng, 2003). By recognizing the importance of identifying sepsis on 
time, the Canadian Paediatric Society recommends screening and treating high risk 
mothers prior to delivering babies to prevent and decrease the risk of development of the 
early-onset sepsis (Barrington, 2007). However, early identification and detection of the 
late-onset sepsis remains a major challenge for clinicians due to vague and minimal 
clinical presentation of warming signs and symptoms of LONS (Ng, 2003). Traditionally, 
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clinical diagnosis of sepsis relies on clinical manifestations and confirmation of 
laboratory tests as a consequence of limited technological support (Haque, 2010; Mahk, 
Hui, Pennie & Kirpalani, 2003; Goldstein, 2005). Recent advanced development in 
clinical diagnostic technologies such as the biomarker detection technology and the 
quantitative cellular measurement promise the availability of improved diagnostic 
techniques (Haque, 2010; Mahket al, 2003; Goldstein, 2005), but they too have 
disadvantages as they rely on daily routine screening, invasive measurements, and a long 
turn-around time for results (Goldstein, 2005; Ng, 2003). Recommendations that early 
recognition and diagnosis of sepsis is beneficial for prevention, promotion, and improve 
clinical outcomes are well documented, thus clinicians desire a clinical support system to 
assist them in early identification of late-onset sepsis to promote better clinical outcomes 
(Chiesa, Panero, Osborn, Simonetti, & Pacifico, 2004).   
Efforts on developing non- invasive techniques to predict and identify late-onset of sepsis 
have accelerated in the last two decades (Chiesa, et al, 2004; Griffin, et al, 2003). Among 
them, Griffin et al. summarized reasons of being difficult and challenging to identify late-
onset sepsis and sepsis-like illness at early stage due to the current clinical diagnostic 
laboratory and imaging techniques (Griffin, et al, 2003; Griffin, et al, 2007). The study 
facilitated them to conduct another study in which they discovered a significant clinical 
finding: the late-onset neonatal sepsis has characteristic early physiological changes 12 to 
24 hours prior to clinically symptomatic presentation, particularly occurrence in changes 
of the heart rate (HR) characteristic of reduced variability and decelerations (Griffin, et al, 
2007; Griffin & Moorman, 2001). Their findings are important in facilitating other 
clinical research and have significant clinical meanings that first provide the clinical 
evidence-based practice guidelines for further clinical research, as well as providing 
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potential opportunities in seeking a proper technique development for the early detection 
of the abnormal behaviour in physiological data to alert clinicians in clinical settings. 
4.5 Quality Improvement in NICU  
Literature in QI in the NICU’s has been getting greater attention than ever before. 
Strategies of QI in the NICU are well documented, such strategies include increase 
collaboration between multi-professional teams (Horbar, et al, 2004; Horbar, et al, 2006;), 
improve process of care through educational programs (Ferrer, et al, 2008), reduce total 
number of medication use to prevent drug side effects, and efforts on reducing incidence 
of nosocomial infection (Payne & Avery, 2011). Although few researches have 
recommended ways of reducing nosocomial infection rate by removing IV catheter as 
soon as completing antibiotics treatment and emphasizing avoid necessary invasive 
contact, strategies of how to reduce nosocomial infection and how to predict potential 
infection are less documented and remain under study. As described in previous sections, 
the NICU contains various medical devices that produce a vast amount of physiological 
data for clinicians to review to facilitate care of neonates. The ideal model for a medical 
monitor has features and capabilities of not only capturing physiological data for 
displaying in seconds, but also extends its capacity to analyze and store data 
synchronization while displaying on screens to assist clinicians to plan treatment to 
prevent disease progress and improve clinical outcomes. Therefore, to design a proper 
computer-aided support tool such as implementation of the CDSS, create a new clinical 
practice model, and develop a framework to improve clinical process and outcomes in the 
NICU to facilitate reduction of nosocomial infection thus to improve quality of care in 




This chapter described the NICU environment, medical devices used, and availability of 
physiological data acquisition and storage in NICU’s in Canada and China. As there is an 
increasing availability of physiological data in the NICU, there is a trend in clinical 
research moving towards how to implement tool to properly utilize physiological data to 
support clinicians in early clinical decision making, with the intent of improving clinical 
outcome.   
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Chapter 5: Proposed a Quality Improvement Framework Design 
5.1 Introduction  
As described in chapter 1, the purpose of this research is to design a framework for the 
implementation and evaluation of clinical decision support systems to support and 
measure quality improvement in healthcare. It enriches quality improvement using 
techniques from patient journey modeling and knowledge discovery. This chapter is 
composed of two sections: the first section describes the overall structure of the 
framework through implementation of the CDSS to support quality improvement; the 
second section describes the plan of evaluation of clinical outcomes and the CDSS in 
further detail. This chapter addresses hypothesis 1 and 2 of this thesis in which a new 
approach is taken to support the QI framework design through building a structure-
process-outcome-evaluation (SPOE) model, based on Donabedian's concept of quality-of-
care framework in combination with the existing CRISP-DM data mining model and the 
patient journey modeling (PaJMa). 
This chapter addresses the following research hypothesises of:  
1. A framework can be defined to support quality improvement through implementation of 
the CDSS 
2. That the framework can be supported by knowledge obtained from analysis of high 
frequency physiological data in real-time 
5.2 Proposed Quality Improvement Framework Design 
This section introduces the framework design for quality improvement primarily where 
the intervention is implementation of the CDSS. For the purpose of QI framework design, 
the QI strategy in this thesis is defined as a means of improving the clinical process and 
enhancing practical performance to improve quality of care in which activities focus on 
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providing optimal patient centric care, effectively utilizing clinical data, increasing 
efficiency, and increasing patient safety through support from the CDSS.  
5.2.1 The SPOE Model Design 
The structure, process, and outcome (SPO) are the three key dimensions that reflects 
Donabedian’s concept of quality-of-care framework (Mitchell, Ferketich & Jennings, 
2007). Donabedian clearly identified a simple cause-effect relationship in his framework 
as he assumed that the structure of healthcare model affects the caring process which 
further has impact on healthcare outcomes (Mitchell, et al, 2007). However, there was a 
lack of attempt for the incorporation of feedback for the continuation of quality 
improvement in his framework.  
Based on Donabedian’s concept of quality-of-care, Curtis and his colleagues extended 
Donabedian’s model of quality-of-care with the addition of an evaluation phase in their 
model, but they failed to utilize objective data to evaluate the process (Curtis, et al, 2006). 








Figure 5-1: The Quality Improvement Cycle 
To date, the concept of QI has been identified as a dynamic cycle that includes phases of 
identifying goals and objectives, planning, implementing and evaluation as illustrated in 
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figure 5-1. Within this cycle, organizational structure such as policy and protocol, model 
of healthcare delivery, practice guidelines, patient-staff ratio, size of the healthcare 
environment and resources are hard factors that directly affect patient movement which is 
part of patient journey and clinical process, thus impact on quality-of-care patient 
received; staff attitude, patient characteristics, and clinical intervention are also 
considered medicate (soft factors) which also affect clinical process and outcomes. The 
implementation and processing phase includes tools that used to support QI and its 
process.  
Based on the QI cycle, the QI framework proposed in this thesis extends Curtis’ model, 
with incorporation of an evaluation phase in the QI model which aims to seek feedback 
for the previous of three phases and to reflect the original framework design for further 
development and modification. In addition it utilises the structure of the CRISP-DM and 
the extended CRISP-TDM models to provide structure for the phases to identify the goals 
and objectives together with planning and evaluation. Support for the implementation 
phase is provided through the use of the PaJMa model to improve delivery of the new 
care process.   
In this proposed framework, organizational structure refers to available resources, 
healthcare delivery model, policy and protocol, practice guideline, healthcare 
environment such as bed space, information technology, and information systems; the 
process documents the sequence and timing of activities that occurs between healthcare 
providers and patients and their families which is the key area that this framework will be 
focusing on; the outcomes refers to final results what’s the goals of the research looking 
for. One of the biggest challenges of this framework is how to integrate the SPOE model 
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with the CRISP-TDM and PaJMa models; it is also one of the unique contributions of the 
thesis.  
This section illustrates the extension made to create the SPOE model as highlighted in 
figure 5-2. Within this model, the evaluation phase is created to evaluate clinical 
outcomes as well as effectiveness of the CDSS to reflect the QI process for further study. 
The proposal conceptual SPOE model in this framework addressed hypothesis 1 of this 
thesis 
“A framework can be defined to support quality improvement through 
implementation of the CDSS”
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Figure 5-2: SPOE Model 
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As presented in figure 5-2, prior to redesign of the SPOE model, expected improvement 
must be made in regards to the identification of needs and areas, the setting of QI goals 
and objectives, environmental scan to identify resources, opportunities and strengths with 
the system, identify expect QI outcomes and gap between current clinical process and 
expect outcomes; cultural elements such as values, beliefs, attitude and expectation are 
crucial in the SPOE model design to ensure reach goals and success in clinical 
improvement. In the designed SPOE model,   
Structure: 
 The size of unit (environmental factor, such as bed space, total number of patients 
in designed area) 
 Staff-patient ratio 
 The numbers, roles, responsibilities of staff 
 Type of medical device used 
 Type of available technology used  
 The integration of CDSS system with the hospital information system  
 Quality of resources, management system, and policy and guideline using 
Process:  
 Using the PaJMa to present patient journey, staff roles and responsibilities, 
information created and captured, technology used, and clinical guidelines 
Expected Outcomes:  
 Defined clinical indicators 
 Patients’ satisfaction  





 Clinical outcomes 
 CDSS 
 Audit and feedback 
 Accompanied by recommended targets 
 Impacts on clinical process  
5.2.2 The Extended CRISP-DM to support QI framework  
This proposed QI framework suggests the combination of the SPOE model with the 
extended CRISP-DM model to allow for a clearer understanding of business of goals 
based on a medical unit structure, followed by process and utilization of clinical data  to 
assist with clinical decision making thus to improve quality-of-care. The following 
section briefly describes integration of the SPOE model and extended CRISP-DM tasks 
completed for the purpose of quality improvement within the context of the framework.   
As described in previous section, the SPOE model has established a structure for QI, due 
to natural characteristics of acute care needs, how to utilize data to support the framework 
process is the key. This section discusses the framework of utilization of data to support 
QI in detail. The section support hypothesis 2 of the thesis “That the framework can be 
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Figure 5-3: Integration of the CRISP-DM and the extended SPOE to support QI framework
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Figure 5-3 presents the new concept of the integration of the CRISP-DM model and the 
extended SPOE model together to support QI, with a particular focus on how CRISP-
TDM will support QI framework to enhance clinical process improvement. The literature 
review section of this thesis has previously introduced the CRISP-DM methodology and 
its recent application and success in healthcare field. It defined the six phases of the 
CRISP-TDM model including business understanding, data understanding, data 
preparation, modeling, evaluation, and deployment (Chapman, et al, 2001). Figure 5-3 
illustrates a supportive relationship between the CRISP-DM and the extended SPOE 
model that is applicable in the QI framework. As other researchers have not previously 
explored such supportive relationship, this new concept creates the unique contribution of 
the thesis. Discussion of the relationship between the CRISP-DM and the SPOE model is 
explored in the remainder of this section.  
Business Understanding:  
The primary purpose of the business understanding phase in the CRISP-DM 
model involves the identification of goals and objectives for the area that will be 
investigated and accomplished. To apply the business understanding phase in the QI 
framework, as illustrated in the figure 5-2, the direction of the SPOE model movement 
presents a cause-effect relationship within the QI framework, which indicates the 
organizational structure obviously directly affects patient journey and clinical outcomes; 
however, this one way cause-effect relationship failed in providing information about 
how and what kind of desired outcomes require structure to be designed in order to 
support its goals. From the business points of review, the expected outcomes demand the 
QI structure to support and process its requirement to reach the goals, thus the subtasks of 
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in the business understanding phase has been used to support both the structure (S) and 
the outcomes (O) process in the SPOE model as presented in figure 5-3.  
Data Understanding and Modeling Understanding:  
The data understanding and modeling understanding of the CRISP-DM phases aim to 
understand characteristics of data, describe the acquired dataset, data exploration to 
ensure the quality of data for mining, select a data mining model to process data, and to 
prepare dataset that will be used for data analysis. A data miner then looks for 
relationships between a predictor and desired outcomes. In this thesis, as illustrated in the 
figure 5-3 diagram, the data understanding and model understanding phases both fall in 
the process component of QI. As the intervention for the QI is a CDSS, it must receive 
data as input and output the results for the CDSS. To successfully implement the QI, a 
mechanism to feed the data to the CDSS must be created that can occur during the day-to-
day function of caring for patients during their patient journey.    
Evaluation:  
The evaluation phase in the CRISP-DM model involves assessment of the data mining 
results for accuracy and generalizability to the initial business goals; it also assesses and 
determines the degree of the CRISP-DM model in meeting business objectives. In the 
redesigned SPOE model, the evaluation phase aims to evaluate whether the clinical 
outcomes and the effectiveness of the CDSS in the QI framework are reached.   
5.2.3 The CRISP-DM specialised tasks to support QI framework in details 
The background section of this thesis has previously introduced the successful application 
of CRISP-DM application in an acute care domain when used to discover new knowledge 
for new pathophysiological indicators for earlier onset detection of certain conditions and 
the previous section discussed the relationship between SPOE model and extended 
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CRISP-DM. This section will detail how the extended CRISP-DM known as CRISP-
TDM gives step by step elements to enable the implementation of the CDSS within the 
clinical setting in support of QI. The summary of elements to document in each step is 
presented in figure 5-4.  
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Specialized tasks of the extended CRISP-DM support QI framework in detail: 
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Figure 5-4: CRISP-TDM as extended to support QI framework 
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Phase one of CRISP-DM: Business Understanding  
In this particular research, as it is a framework, the expected outcomes have to be taken 
into consideration when determining business understanding as it is part of business 
goals. Thus, the business understand phases including structure and outcomes 
 Clinical application domain 
 Case condition 
 High dependency environment  
 Patient population base 
 Clinical objective 
 Clinical success criteria 
 Quality improvement goals 
 CDSS goals 
Phases two, three, and four of CRISP-DM: data understanding and data modeling in 
supporting the QI process 
The data understanding phase of CRISP-DM aims to understand and prepare dataset to be 
used for quality improvement. Careful analysis of existing data and selection of data for 
QI are the key process to ensure QI support. The primary focus of this thesis is on using 
existing patient data obtained from the CDSS in real-time therefore the activities in data 
preparation and data modeling in phases three and four respectively are very similar to 
those described in the previous section.  
Phase five of CRISP-DM: Evaluation to support clinical outcomes and CDSS:  
Within the evaluation phase in the CRISP-DM, in addition to evaluate the model, there is 
also an option to test the model in the real world if time permits (Chapman, et al, 2000). 
For the purpose of creating a conceptual QI framework supported by the CDSS, this 
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thesis assumes to implement the CDSS in clinical settings to expand the CRISP-DM 
context in more broad clinical areas, therefore evaluation phases will be focusing on  
 Testing expected clinical outcomes  in real clinical settings 
 Assess DM with results with respect to the organization’s business success 
criteria 
 Pre-intervention and post-intervention result comparison and outcomes 
evaluation  
 Through a real-time analysis of physiological stream date to test whether or the 
framework have positive impact on increasing clinical process  
 Prove that QI can be supported by utilizing real-time physiological data 
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Figure 5-5: Clinical Process Presentation in the PaJMa Model 
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Figure 5-5 presents a clinical process in the PaJMa model. The PaJMa model has been 
briefly introduced in the background section. As the purpose of this thesis is to design a 
framework to improve clinical process and enhance clinical practice, therefore within the 
process of QI, the PaJMa plays a key role in intuitively presenting how the clinical 
process will be improved based on evidence based practice and/or clinical guidelines that 
supports patient-centric care. New technology will be used to increase efficacy by 
reducing waiting time, it will also demonstrate how patient centric care will be identified 
to ensure patients’ safety, as well as displaying individual professional roles and activities 
involved in neonatal care and their contribution. 
5.3 Method of evaluation of clinical outcomes and the CDSS 
Chapter two has reviewed different evaluation methods used for evaluating the CDSS in 
various research studies, including a randomized controlled trial, nonrandomized 
controlled triall, a quasi-experimental time-series design, and questionnaire. The section 
describes an evaluation method used to evaluate the clinical outcomes and the CDSS.  
A before and after research method was chosen to measure the clinical outcomes and the 
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Figure 5-6: Evaluation of the CDSS 
The before and after study has its advantages in measuring changes in a phenomenon, 
situation, and attitude as it is “most appropriate design for measuring the impact or 
effectiveness of a program” (Kumar, 2005. p. 95). A comparison between pre and post 
intervention will be made to measure the expected clinical outcomes and determine 
whether the CDSS support QI, which clinical indicators will be used to evaluate the 
effectiveness of the CDSS, clinical effectiveness, patient satisfaction, quality of service, 
and efficiency of service delivered. This section demonstrates hypothesis 3 and 5 of the 
thesis 
“The framework can be demonstrated to support clinical process improvement” 
and “The clinical decision support system can effectively support clinical decision 
making”    
5.4 Summary of the Proposed QI Framework 
This chapter has addressed research hypotheses one and two where the clinical context is 
added in the existing CRISP-DM framework to extend CRISP-DM capacity in the area of 
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QI. The proposed framework brings together with the concept of quality improvement, 
clinical management, and clinical research in an environment that will quality of care will 
be improved by implementing the CDSS which has been demonstrated its capacities in 
analysis of real-time physiological data along with an explanation of how the PaJMa 




Chapter 6: A Case Study Demonstration 
6.1 Introduction 
Chapter 5 described the QI framework design, directly addressing the research questions 
introduced in chapter 1. In this chapter, a case study is presented to demonstrate the 
designed framework for QI and to demonstrate how the evaluation of the CDSS would 
occur what within the context of the cross-cultural setting. This chapter supports 
hypotheses 3, 4, and 5 of the thesis: 
3. The framework can be demonstrated to support clinical process improvement 
4. The framework can be demonstrated with the healthcare setting where clinical 
practice is routinely taking place in different cultural settings 
5. The framework can be used to support the measurement of the effectiveness of the 
clinical decision support system to support clinical decision-making and improve 
healthcare outcomes  
This chapter also demonstrates the successful integration of the extended SPOE model, 
the CRISP-DM model, and the PaJMa model together, to facilitate with utilization of 
real-time data in improving clinical processes and enhance clinician performance for QI 
through the case study.  
As detailed in chapter 1, the objectives of this constructed framework include: assisting 
clinicians in adapting to the modern high tech clinical environment; maximizing the 
utilization of available real-time data to assist with clinical decision-making; improve 
routine clinical practice supported by the CDSS; and implementation of the CDSS to 
promote better quality of care and clinical outcomes throughout the entire neonatal 
journey in the NICU. The designed framework is a new innovation in the NICU field.  
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The remainder of this chapter is structured as follows: Section 6.2 introduces the clinical 
problem; Section 6.3 introduces the current NICU clinical practice process in Canada and 
China; the entire framework is presented in 6.4 through a case study based on 
demonstration of late onset of neonatal sepsis in NICUs in Canada and China; and 6.5 
provides a discussion of this framework to conclude the chapter.  
6.2 Clinical Problem 
Hospital associated infection such as neonatal sepsis has a high prevalence in the low 
birth weight and premature infant population (Canadian Paediatric Society, 2007). 
Clinical statistics have indicated that neonatal sepsis has been considered a major cause of 
neonatal mortality and morbidity in the neonatal population (Canadian Paediatric Society, 
2007). The majority of neonates who are admitted in the NICU have developed complex 
conditions, thus they require close monitoring to prevent critical complications. In 
addition to complex medical status, neonates’ inability to express their feelings, rapid 
changes in their condition and disease development makes their cases more difficult for 
clinicians to make the best clinical decisions in regards to establishing the most 
appropriate treatment plan to promote optimal clinical outcomes; as a consequence of 
above circumstances, clinicians must rely on diagnostic tests to support their decision of 
treatments.  
6.2.1 Clinical decision making issues in regards to diagnosis of late onset sepsis 
Clinically, neonatal sepsis is categorized as early onset and late onset sepsis, in 
accordance with onset of clinical signs and symptoms (Canadian Paediatric Society, 
2007). Of those diagnosed with early onset sepsis, 85 % to 90% of neonates have clinical 
signs and symptoms occurring in the first 24 hours of life, 5 % -10 % of them have 
clinical signs and symptoms present at 24-48 hours after birth, and a small group of 
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neonates have clinical signs and symptoms occurring in 48-72 hours of their life 
(Anderson, Berry, Belling, & Ohning, 2012). Late onset sepsis presents itself 
approximately at 4 to 90 days of life and is mostly acquired from the surrounding 
healthcare environment (Anderson, et al, 2012).  
To date, the diagnosis, prediction, and confirmation of neonatal sepsis remains a 
significant challenge for clinicians that may delay clinical decision making about the 
treatment plan. Clinically, the characteristics of the development of neonatal sepsis 
include rapid progression but subtle initial clinical signs and symptoms such as, 
instability of temperature, tachycardia, poor peripheral perfusion, and respiratory distress 
(Anderson, et al, 2012). These described symptoms are too general to detect underlying 
causes (Anderson, et al, 2012). In other words, all these symptoms are not significant 
indicators to identify a specific disease, which increase the difficulty of conforming the 
clinical diagnosis thus delay planning of care and treatment (Anderson, et al, 2012). 
Although there are many advanced diagnostic tests that have played important roles in 
diagnosing and confirmation of neonatal sepsis, include the using of biological markers 
for neonatal sepsis identification and diagnosis; some of these tests have the disadvantage 
of: low sensitivity and specificity in early confirmation; they are expensive;  unavailable 
in routine practice; and  invasive to body system (Litmanovitz, 2008). Therefore, in many 
cases, clinicians are unable to rely on test reports to assist their decision-making.   
In a clinical setting, if an infant is suspected to have an infection; the infant should be 
assessed and treated immediately following a prompt full diagnostic evaluation. Any 
delay in diagnosis of such a condition between gaps of presentation of clinical signs and 
being treated will increase risks of  poor outcomes and prognosis, thus negatively 
impacting the neonate’s quality of life and resulting in an increase length of stay, cost, 
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and resources (e.g. number of days requiring the use of antibiotics) (Anderson, et al, 
2012). Studies indicate early onset sepsis is mostly caused by mothers and preventive 
strategies have been in place to prevent development of early sepsis for those infants who 
are gestation greater than 35 weeks and at high risk of developing sepsis (Canadian 
Paediatric Society, 2007); however, recommendation and strategies for preventing and 
predicting late onset of sepsis in the neonatal population need more attention (Canadian 
Paediatric Society, 2007). There are many reasons contributing to the current difficulty in 
diagnosing late onset sepsis in a timely manner. One of them is due to the lack of an 
effective clinical decision support system in the NICU to assist clinicians to monitor risky 
infants routinely, also to facilitate them to understand, interpret, and utilize data from 
medial monitors in a timely manner. In such circumstance, the implementation of the 
CDSS to effectively support clinicians’ decision-making has significant clinical meaning 
to prove invaluable in the effort of caring for septic neonates to improve quality of care as 
well as clinical outcomes. This framework makes recommendations for clinicians to 
utilize available data obtained from the medical devices to make positive prediction and 
speed up the decision making process to improve clinical process to ensure the quality of 
care they provide.  
6.2.2 The potential of using of high technology to support clinical decision-making  
The case study demonstration illustrates the framework’s ability to assist clinicians in 
establishing a quality improvement initiative for understanding real-time physiological 
data acquired from medical monitors, supporting early detection of late onset sepsis, and 
assist clinical decision-making to improve clinical practice supported by the CDSS. Late 
onset neonatal sepsis is an ideal condition to demonstrate routine clinical process 
improvement by utilizing real-time physiological data to support clinical decision-
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making. The framework allows clinicians to initiate early clinical assessment, full 
diagnostic evaluation, update plan of care, and take early intervention to deal with a 
complex medical condition, as well as improve awareness by the clinical team for 
reduced risk for disease development thus to improve clinical outcomes and quality of 
care through a method of changing process of caring, to improve QI.  
This case study demonstrates the following research hypothesis:  
3. The framework can be demonstrated to support clinical process improvement 
4. The framework can be demonstrated with the healthcare setting where clinical 
practice is routinely taken place in different cultural settings 
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6.3 Current NICU Clinical Practical Processes Presentation  
The clinical processes in Canada and China are similar to each other as they both follow 
the international guidelines; however, there are slight differences because of different 
cultural background and clinical practice model used in different settings. The individual 
clinical practical process in Canada and China will be presented in PaJMa model.   
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Figure 6-1: NICU Clinical Practice Process in Canada and in China 
Figure 6-1 presents the journey of current clinical practice process, clinicians’ roles, 
clinical guidelines and technology are currently using in Canada and in China in the 
PaJMa model. In The Hospital for Sick Children in Toronto, clinicians use international 
evidence-based practice guidelines and protocols to guide their clinical process: in step 1, 
a baby is admitted in the NICU for medical reasons and care needs other than a septic 
condition; a neonatologist and a NICU nurse conduct their initial assessment and 
document it in the EHR (highlighted in greenish color): the baby is connected with 
medical devices to monitor his/her vital signs which their physiological data including 
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ECG with HR, RR, BP, IRW, SpO2 together with the derived pulse rate will be detected 
for monitoring the baby’s condition. The baby’s physiological data is checked hourly to 
continue monitoring the baby while he/she is receiving the initial treatment in the entire 
journey of being treated in the NICU; the baby will be discharged from the NICU from 
The Hospital for Sick Children after the completion of treatment and he/she is medically 
stable. However, step 2 shows that if any abnormal signs and symptoms of septic 
infection occur during the treatment period, the nurses report it to the neonatologist for 
further investigation. The neonatologist will assess and investigate in more depth to see 
whether the occurrence of abnormal vitals sign are caused by non-response to treatment 
or the infant is developing a new condition such as sepsis. If the baby is expected to 
develop a new condition, he/she will have more laboratory tests to go through and will 
receive antibiotics treatment is suspicious with sepsis. The normal laboratory turn-around 
time is about 2 to 4 days, if the laboratory test confirms “yes, positive blood culture 
indicate sepsis”, antibiotics treatment will continue until completed; if the laboratory text 
confirms “no, negative blood culture”, then the delivery of antibiotics will stop 
immediately. There are two problems in such clinical process: delayed detection of septic 
infection until clinical symptomatic appearance and long laboratory turn-around time 
which delays the clinical diagnosis thus delay the treatment initiation.  
6.3.2 NICU Clinical Process in China 
Figure 6-1 also presents the journey of current clinical practice process, clinician’s roles 
in the process of caring a neonate, and clinical guidelines and technology are currently 
using in China. At this stage, the clinical processes in the Children’s Hospital of Fudan 
University in Shanghai, China are similar to those in Canada because they both follow the 
international evidence-based practice guidelines and protocols: in step 1, a baby is 
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admitted in NICU for medical reasons and care needs other than a septic condition; a 
neonatologist and a NICU nurse conduct their initial assessment and document the base 
line information in a paper chart. A significant difference between The Hospital for Sick 
Children and the Children’s Hospital of Fudan University are highlighted in red color in 
the figure 1: instead of documenting in the EHR in the NICU in The Hospital for Sick 
Children, paper format documentation is currently used in China which clinicians have to 
manually read the physiological data from medical devices and write in a paper chart 
hourly. In step 2, the baby is connected with medical devices to monitor his/her vital 
signs. A green highlight indicates that only pulse rate and blood oxygen have been 
monitored in China while the infant is being treated with the admission diagnosis after 
treatment plan is completed. The NICU nurses continue to monitor the baby while they 
are receiving the initial treatment in the step 2; the baby will be discharged from NICU 
after the completion of treatment and he/she is medically stable. However, step 3 shows 
that if any abnormal signs and symptoms of septic infection occur during the treatment 
period, the nurses report it to the neonatologist for further investigation. The 
neonatologist will then conduct further investigation to determine if the occurrence of 
abnormal vital signs is caused by non-response to treatment or if the infant is developing 
a new condition such as sepsis. If the baby is expected to develop a new medical 
condition, he/she will have more laboratory tests to go through and will receive 
antibiotics treatment is he/she is expecting developing sepsis. The normal laboratory turn-
around time is about 2 to 4 days, if the laboratory test confirms “yes, positive blood 
culture indicate sepsis”, antibiotics treatment will continue until completed; if the 
laboratory test confirms “no, negative blood culture”, then the delivery of antibiotics will 
stop immediately. There are two problems in such clinical process: detection of septic 
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infection is delayed until the appearance of clinical symptoms followed by long 
laboratory turn-around time which in turn delays the clinical diagnosis thus delaying the 
treatment initiative.  
6.4 Framework Demonstration 
In this section, the designed framework will be demonstrated through the implement of 
the CDSS to improve the clinical process (highlight in figure 6-2) in the NICU settings 
where this research is performed. This addressed hypothesis of 5 in this research:  
5. The clinical decision support system can effectively support clinical decision making  
91 
 
6.4.1 The SPOE model to Improve Clinical Process 
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Figure 6-2: SPOE model in case study 
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6.4.2 The CRISP-DM model integration in the SPOE process 
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Figure 6-3: CRISP-DM integrate with the SPOE model in case study 
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In this framework, phase one, two, three, and four of CRISP-DM are presented and 
described in details in the chapter 5.2, in addition to the clinical context is also added and 
addressed in phase one. This section focuses on phase five and six in which the utilization 
and analysis of physiological data are contained within CRISP-DM through the case 
study of this research to demonstrate how changes in clinical process to support clinical 
decision making contribute to early intervention to improve quality of care in NICU using 
the late onset neonatal sepsis case and its representation within an updated PaJMa. 
6.4.2.1 CRISP-DM Business Understanding in the Clinical Process 
The purposes of the CRISP-DM business understanding phase in this research are to: 
identify overall business objectives, determine business goals, implement the designed 
framework in clinical settings, investigate whether the framework will contribute to 
quality improvement in NICU, and evaluate the effectiveness of the CDSS. In the other 
words, the business understanding phase is the stage of setting goals to investigate 
whether the CDSS effectively support the clinical decision making, has impacts on 
changing clinical process and clinical outcomes, increasing efficacy, and improve quality 
of care. Therefore, the components of the research context in the business understanding 
phase are:    
 Clinical application domains: there are two cross-cultural collaborative NICUs 
where this research is preformed: The Hospital for Sick Children in Toronto and 
the Children’s Hospital of Fudan University, Shanghai, China. The Hospital for 
Sick Children is a level III neonatal care unit with the most advanced medical 
devices and highly trained professionals to monitor neonates. The Children’s 
Hospital of Fudan University is one of the biggest children’s hospitals with 
advanced medical equipment in China   
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 Neonatal condition: late-onset neonatal sepsis condition. The unique 
characteristics of late onset of neonatal sepsis in early stages include reduced 
variability and decelerations of heart rate in 12 to 24 hours prior to clinically 
symptomatic presentations (Griffin, et al, 2001) provides us the evidence-base 
practice guideline for research and an opportunity to work on early detecting 
abnormal reduced variability of heart rate to support clinical decision making  
  Clinical objectives: to extend the process mining and abstractive mining research 
into routine clinical practice to implement research knowledge in real settings to 
improve clinical practice process, determine whether the use of the designed 
framework will improve clinical process and outcomes and increase efficiency; 
whether the use of the CDSS will effectively support clinical decision making to 
improve clinician’s performance 
 Quality improvement goals: to provide patient centric care by focusing on 
individual situation and needs; to improve clinical outcomes by utilizing real-time 
physiological data analysis; and to improve clinical practice process by getting 
support from the CDSS in combination with the PaJMa model 
 Evaluation of CDSS goals: to investigate whether or not the Artemis system has 
capabilities in assisting with clinical decision making to support QI 
6.4.2.2 CRISP-DM Data Understand and Data Preparation in Clinical process 
The second and third phases of CRISP-DM are data understanding and data preparation, 
in which data miners attempt to understand data requirement, initial data collection, and 
criteria for data collection, descript method of data capture and value (Chapman, et al, 
2000). Data collection for this research through the Artemis platform was captured in 
real-time and transmitted from two locations to a server located in the Health Informatics 
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Research Laboratory at the University of Ontario Institute of Technology, Oshawa, where 
the data was stored. Data collection from The Hospital for Sick Children commenced in 
August 2009 and at the Children’s Hospital of Fudan University in December 2012. The 
study relating to the detection of late onset sepsis represents the primary use of this data. 
There are slight differences in clinical variables used in this research between Canada and 
China. In Canada, the Philips Monitor MP 70 used to monitor neonates while the Philips 
Monitor MP 50 used in China (Table 6-1). In addition to the usage of different monitors, 
the Artemis system has been integrated with hospital EHR and laboratory system in The 
Hospital for Sick Children; however, the electronic health record (EHR) and laboratory 
system is currently not used in the Children’s Hospital of Fudan University in China 
which required a slight infrastructure modification (has been completed in other team 
research). These differences in clinical variables and data storage one must take into 
consideration when it comes to data analysis to support decision-making.  
 Data types from Canada: BP, RR, SpO2 , HR, ECG 
 Data types from China: SpO2 , Pulse rate (instead of HR in Canada) 
NICU Canada NICU China   
Philips Monitor MP 70 Philips Monitor MP 50  
Physiological data stream Types Physiological data stream Types 
Blood pressure: diastolic Measurable Blood pressure: diastolic Measurable 
Blood pressure: systolic Measurable Blood pressure: systolic Measurable 






Heart rate Measurable Pulse rate Measurable 
Respiration rate Measurable Respiration rate Measurable 
Table 6-1: Physiological data used for analysis in Canada and in China 
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6.4.2.3 CRISP-DM Data Modeling in the clinical process 
The phase of data modeling was completed in previous research by Catley, et al in 2009 
that used the modeling structure in CRISP-TDM (Figure 6-3) through a quantitative 
analysis of the temporal abstractions performed on physiological streams. The difference 
in data types and system integration required modification to the Artemis infrastructure in 
order to get accurate data mining results to support real-time analysis:  
 In Canada, physiological BP, RR, SpO2, HR, and ECG data streams were 
processed with the integrated hospital information system and the laboratory 
system to perform the process of data mining to obtain new knowledge for data 
analysis as presented in table 6-1 
 In China, only  SpO2 and pulse streams are automatically collected for data mining 
due to neither the hospital information system, nor the laboratory system have not 
been integrated in the Artemis system as presented in table 6-1. As a result 
information from these systems needed to be collected manually for the data 
mining 
6.4.2.4 CRISP-DM Evaluation in the SPOE model 
The CRISP-DM evaluation phase allows researchers to test the application in real settings 
to evaluate whether or not the designed framework meets the business objectives 
(Chapman, et al, 2000). In this phase, the modified clinical practice process model 
implemented in late-onset sepsis case combines with the PaJMa model in the two cross-
cultural NICU settings to evaluate whether or the framework will improve clinical 
outcomes. 
As described in 6.3, the clinical process in NICU includes three steps: assessment 
(clinical data collection from interview patients and clinical examination to obtain base 
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ling information), planning of care (treatment planning), and re-assessment (assess 
individual response to treatment and adjust treatment if needed) prior discharge home 
(Figure 6-1).   
 Figure 6-5 uses the PaJMa model to present the framework in the late onset neonatal 
sepsis case study in The Hospital for Sick Children in Toronto. Following the clinical 
guidelines, as soon as the neonates are admitted into NICU, all the administrative, 
obstetric and gestational history, delivery, and demographic information, and base line 
physiological data are obtained and stored in EHR that has been integrated in Artemis 
System (step one of practice process). To better monitor the neonates’ condition and 
support the clinicians’ decision making and assist them adapt in the high technique 
environment, we introduce the Artemis system at the beginning of the clinical process in 
which high risk infants will be monitored closely. The neonate’s physiological data (e.g. 
HR, RR, BP, SpO2, and ECG) is not only displayed on screen for clinicians’ review; they 
are also simultaneously acquired and processed via the Artemis system for real-time 
online analysis. Neonates are monitored closely while they are receiving treatment, if no 
abnormal vital signs are detected, they will be discharged home after completion of their 
treatment. However, if the Artemis system detects educed heart rate variability above the 
threshold allowed without a complementary fall in the respiration rate variability; the 
clinician can use this together with other indicators to start the testing and antibiotics. At 
this time, although neonates may not present any clinical signs and symptoms, the alert 
assists clinician in changing their treatment usually after clinical feature appear, to take 
early intervention which they start order laboratory investigations and start antibiotics to 
treat neonates immediately. The neonatologist will then evaluate laboratory results to 
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adjust treatment plan based on confirmation of laboratory tests and other clinical signs 
and symptoms other than sepsis. 
6.4.3 CRISP-DM Deployment  
The deployment phase documents QI outcomes by using CRISP-DM method as structure, 
developing a new clinical process based on evidence-based practice and utilization of 
physiological data in real-time, generating a new evidence clinical practice process based 
on the case study of the demonstration. As a result of this demonstration:  
 The QI framework can be defined in NICU by using CRISP-DM method 
 As presents in PaJMa model, quality of care can be improved through analysis 
physiological data in real-time 
 The framework can be implemented in different cultural setting, although culture 
different influence of clinical practice, the framework can be adjust according to 
cultural condition to support clinical decision making 
 The Artemis system has capacity to support clinical decision making in different 
cultural settings  
 QI needs a structure to provide a blueprint for clinicians; and the designed QI 
framework actively guides clinician performance and behaviour to in order to 
quality improvement  
6.5 PaJMa Model in Quality Improvement Research  
Throughout the case study, the PaJMa model has its unique contribution to QI in a way 
of:  
 Presentation of data flow: the PaJMa presents different data from different clinical 
perspectives and data flow through the journey of patient in NICU which promote 
clinicians’ decision making in choose an optimal care plan to improve outcomes  
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 Patient centric care: individual infant’s parents are involved and participate in the 
process of caring which presented in the PaJMa. Parents’ interaction with 
clinicians from different perspectives will empower them involving in the clinical 
decision making, which encourage parents participation in improving health care 
delivery; it will promote patients satisfaction. During this process, PaJMa acting 
as an interactive tool that allows parents to explore relevant information that can 
foster shared clinical decision making process, which also contribute to assist 
clinical decision making  
 Increase communication: in NICU, clinicians are unable to communicate with 
neonates, on-going communication with parents who are the primary care givers 
provides patient-centre care, give them opportunities to express their experience, 
perspective on care and will promote increase satisfaction rate. This enables 
PaJMa to act as a tool to translate family satisfaction data into quality 
improvement (Dodek, Heyland, Rocker, & Cook, 2004).    
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Figure 6-4: Modified Clinical Process in Canada 
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Figure 6-4 illustrates the implementation of the framework in The Hospital for Sick 
Children: as presented in step 1, as soon as the neonate is admitted to the NICU, the 
baby’s administrative, obstetric and gestational history, delivery, and demographic 
information are obtained, stored in the EHR. For high risk infants who were premature 
and had low birth weight, they will be assessed by neonatologists and nurses to get base 
line information and document in the EHR. The neonate will then be connected with 
medical devices to monitor their vital signs while all physiological data ECG, HR, RR, 
BP, and SpO2 will be acquired and processed by the Artemis system for real-time online 
analysis. The neonate is monitored closely while he/she is receiving treatment for initial 
medical problem. If no abnormal vital signs are detected, they will be discharged home 
after completion of the treatment. However, if the Artemis system detects reduced heart 
rate variability over the threshold allowed without a complementary fall in the respiration 
rate variability; the clinician can use this together with other indicators to start the testing 
and antibiotics. At this time, although neonates have no clinical signs and symptoms, the 
neonatologist will review all collected base line information in conjunction with 
reviewing individual demographic information in the EHR to decision whether the 
neonate is undergoing development last-onset sepsis or not. The alert assists clinicians to 
change their thinking and clinical practice to take early intervention which they start order 
laboratory investigations and start antibiotics to treat neonates immediately. The next step 
is to confirm the diagnosis of late onset sepsis: the neonatologist will review all 
laboratory results combined with clinical feature to modify the treatment plan; if the 
laboratory confirms positive detection of infection in blood work, the treatment will need 
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Figure 6-5: Modified Clinical Process in China 
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Figure 6-5 illustrates the implementation of the framework in The Children’s Hospital of 
Fudan University. Similar to clinical process in The Hospital for Sick Children, as soon as 
neonates are admitted to the NICU, all the administrative, obstetric and gestational 
history, delivery, and demographic information are obtained and document in the paper 
chart. For high risk infants who were premature and have low birth weight, they will be 
assessed by neonatologists and nurses to get base line information and document in their 
charts. Following that, the neonate will be connected with medical devices to monitor 
their vital signs while physiological data including pulse and SpO2 will be acquired and 
process to the Artemis system for real-time online analysis. Neonates are monitored 
closely while they are receiving treatment. If no abnormal vital signs are detected, they 
will be discharged home after completion of the treatment. However, if the Artemis 
system detects reduced heart rate variability consecutively above the threshold allowed 
without a complementary fall in the respiration rate variability; the clinician can use this 
together with other indicators to start the testing and antibiotics treatment. This is 
presented in figure 6.4.3. At this time, although neonates may not present with clinical 
signs and symptoms, the neonatologist has to review all collected base line information in 
conjunction with reviewing individual demographic information in the chart to decision 
whether the neonate is developing last onset sepsis or not. The alert assists clinicians to 
change the plan of treatment to begin early intervention by ordering laboratory tests and 
antibiotics to treat neonates immediately. The next step is to confirm the diagnosis of late 
onset sepsis: the neonatologist will review all laboratory results and combines with 
clinical features to modify the treatment plan, if the laboratory confirms positive detection 
infection in blood work, the treatment needs to be completed. The treatment will be 
discontinued if laboratory results are negative. 
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6.6 Evaluation of the CDSS 
This section describes the method used to evaluate the clinical outcome and effectiveness 
of the CDSS. There are two comparison charts that will be made to provide evidence of 
the improvement of quality and the CDSS. One chart is made to compare between pre- 
and post- intervention to evaluate the effectiveness of the CDSS which includes indicators 
such as: evaluation of laboratory results that confirm or reject the diagnosis, clinical 
process of care, duration of antibiotics used, total cost of care, length of stay, patient 
satisfaction, quality of service, and efficiency of service delivered. The second chart 
provides a comparison between different cultural settings. This section demonstrates the 
hypothesis 3 and 5 of the thesis:  
3: That the framework can be demonstrated to support clinical process improvement and 
5: The clinical decision support system (the Artemis system) can effectively support 
clinical decision making  
6.6.1 Evaluation Method  
Method: a before-and-after non-experimental study design 
Rational: the before-and-after study design provides primarily evidence for intervention 
effectiveness, especially when supplemented with complementary information, it is the 
most appropriate study design sued to evaluate the effectiveness of the CDSS 
Before: baseline measurement documentations at time of Artemis alarm onset, any change 
nature and frequency of the problem and its consequences 
Interventions (Randomization and Masking): Implement the CDSS to acquire, process, 
and analysis physiological data in real-time to alarm clinicians. In this case, use the 
Artemis system to monitor ECG with heart rate, respiratory rate, blood oxygen saturation 
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characteristics in The Hospital for Sick Children; and use the Artemis system to monitor 
pulse rate and blood oxygen saturation in Children’s Hospital of Fudan University.  
After: After admission, neonates will be contacted with the CDSS to monitor their 
condition. Document the time of onset of the Artemis alarm (onset, any changes in RR, 
HR, SpO2  readings) and duration, time of clinical manifestation (maybe vary in subjects 
depends on clinicians’ observation), and time of laboratory confirmation.   
Populations and sample size: low birth weight and premature neonates who admitted in 
the NICUs 
Sample size: 100 neonates in The Hospital for Sick Children in Canada while 100 in The 
Children’s Hospital of Fudan University in China 
Result: compare results between pre and post the implementation of the CDSS 
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Figure 6-6: Evaluation of the CDSS 
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Data collection and data management:  
Pre intervention data collection: base line data will be collected at the time of admission; 
then hourly after admission 
Post intervention: data collection starts automatically as soon as the neonate is been 
monitored by the Artemis system. The physiological data include time of alarming and 
duration (e.g. onset, any changes in RR, HR, SpO2 readings).  
Clinicians have to manually document time of clinical manifestation appearance (which 
may vary in subjects depending on clinicians’ observation), and time of laboratory 
confirmation.  
Expected outcomes: 
  Primary outcome: looking for the total number of identification and prediction of 
later onset sepsis cases (in two groups in Canada, two groups in China) 
Secondary outcome: looking for the total number of confirmation case, confirmed with 
(laboratory result, neonatologist: clinical sign and symptoms) in Canada and China 
Third outcome: observation of validation rates in two different settings 
6.6.3 Pre- and post-intervention comparison  
A pre-and post-intervention comparison is presented in table 6-2:  
 Pre- Post- 
Laboratory   
Time to order diagnostic test   
Turn-around time (waiting time)   
Clinical process   
Time to order diagnostic tests   
Time to order antibiotics   
Length of antibiotics using   
Length of stay   
Total cost   
Parents’ satisfaction    
Table 6-2:  Pre- and post-intervention comparison 
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6.6.4 Comparison of differences in Canada and China 
 Canada China 
Human factors:   
Difference in Philosophy    
Difference in cultural, 
examples 
Pain management in 
infants 
Do not use pain medication in 
infants 




Attitude of facing problem   





The Artemis system    
ECG   No  
Data Capture   
Data transmission   
Data storage    
Data analysis   
Data integration  Hospital system 
integration  
Locate monitor system 
Interpret knowledge   
Difference monitors 
(functional differently)   
Philips Monitor MP 70 Philips Monitor MP 50 
Study population  Outborn infants Outborn infants 
Data collection    
Data presentation different 
(information different) 
  
How we are going to handle 
the difference  
  
Patient Journey Modeling 
(Capacity difference) 
  
Hospital information system  Integrated N/A 
Table 6-3: Comparison of difference in Canada and China 
 
6.7 Discussion and summary of the case study demonstration  
This chapter has addressed research hypotheses 3, 4 and 5where the clinical process is 
improved by implementing of the SPOE model that integrates the CRISP-DM and the 
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PaJMa model. The clinical case demonstrates how the CDSS utilizes real-time data to 
support clinical decision-making which clinical process was presented that extend 









Chapter 7: Conclusion 
This thesis has presented a framework for quality improvement and evaluation of the 
clinical decision support system in the NICU environment. The framework is 
demonstrated through a case study supported by implementation of the CDSS that 
captures, stores, and analyzes acquired physiological data in real-time. The conclusion 
chapter provides a summary of the proposed framework that is described in previous 
chapters, discusses clinical implication, illustrates contributions of the thesis, identifies 
limitations of the thesis, and highlights impact and future research opportunities. The 
reminder of the chapter is organized as follows: section7.1 provides a summary of the 
proposed framework; section 7.2 discusses clinical implication; section 7.3 describes 
contributions of the thesis to the research area; section 7.4 identifies limitation of the 
research; section 7.5 provides potential opportunities and future in the research and 
advancement of the proposed framework; section 7.6 presents the final conclusion to this 
thesis paper.  
7.1 Summary 
This thesis presents a framework for QI and evaluation of the CDSS to support and 
measure QI through implementation of the CDSS in the NICU environment. The 
proposed framework extends the SPO model to the new practical SPOE model, uses the 
CRISP-DM data mining principle to specifically address the research problems, together 
with the PaJMa model to improve clinical process to assist clinician’s decision making in 
NICU environment in cross-cultural settings. The contributed framework is unique in the 
sense of utilizing physiological data in real-time to support clinical decision making, 
though implementation of the CDSS to improve quality of care.  
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A literature review was completed for the purpose of exposing current status of utilization 
of the CDSS, identify the needs of, and potential opportunities of designing this 
framework; definitions of QI, current researches in QI, and methods of CDSS evaluation 
were reviewed in chapter two. The literature review focused on two major areas: QI and 
evaluation of the CDSS. The first section of the review focused on the existing studies of 
QI, which results indicated although many QI projects have been introduced and 
implemented in the last two decades, there are some existing issues in current status: such 
as an absence of using real-time data to structure QI in the NICU environment; lack of 
using measureable variables to improve clinical process and outcomes; limited 
implementation of QI and description of QI process in real-time in routine practice setting 
remains under study; et al.   
The second section of the literature review focused on existing studies of evaluation of 
the CDSS and current issues. Methods of evaluating the CDSS are vary according to 
different perspective and types of the CDSS needed to be evaluated; the literature results 
found there are some issues remaining that are under studied, such as the traditional 
health science study is not applied to high frequency health informatics environment 
because it does not take physiological data into consideration when it comes to supporting 
clinical decision making; the application of IT in critical care setting is not only focused 
on increased utilization to enable the improvement through QI, but also the desires for 
outcomes that effectively support that clinical decision making to increase efficiency; the 
impact of CDSS on clinical process and outcomes should be measured by a designed 
evidence based scientific study; and encourage clinicians to adapt the high information 
technology environment thus revision of practice model based on evident practice. The 
results of the literature review provided information and opportunities for research and an 
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impetus for the clinical researcher to design this framework to address above problems 
and solutions to solve these problems to fit the gaps. Therefore, the following 
hypothesises were generated:  
1. A framework can be defined to enable the quality improvement through 
implementation of CDSS in the NICU environment 
2. That the framework can by supported by knowledge obtained from analysis of high 
frequency physiological data in real-time  
3. That the framework can be demonstrated to support clinical process improvement  
4. That the framework can be demonstrated within the healthcare setting where clinical 
practice is routinely taken place in different cultural settings 
5. The clinical decision support system can effectively support clinical decision 
making  
Chapter 3 provided background information related to the proposed framework design in 
three main themes: the CRISP-DM methodology, the PaJMa model and its 
implementation in clinical settings, and the Artemis CDSS. This framework extends 
previous SPO model to SPOE practical model by implementing of the CDSS, together 
with integration of CRISP-DM and PaJMa; previously there was little research that has 
been completed by other members within the Health Informatics Research Team at the 
UOIT, therefore, this research and its outcomes from team members were also described 
in this chapter which demonstrates evidences to ensure success in designing of the 
framework. 
Chapter 4 introduced the contexts of the neonatal intensive care unit globally which is 
application domain for the framework. Through full description of similarities and 
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differences in two different cultural settings to ensure the designed framework can be 
successfully implemented in the two settings. 
The framework was introduced in chapter 5. The chapter described and discussed the 
framework design in details to addresses research hypothesises of  
1. A framework can be defined to support quality improvement through 
implementation of the CDSS;  
2. That the framework can be support by knowledge obtained from analysis of high 
frequency physiological data in real-time 
This chapter described the extension of the SPO model to the SPOE model, together with 
the CRISP-DM and the PaJMa to improve clinical process to reach the goals of support 
QI. This chapter also introduced the before-after method as the chosen evaluation method 
for using in the framework for evaluation of the CDSS.   
Chapter 6 demonstrated and explained the designed framework through a case study of 
late onset neonatal sepsis in different cultural settings. The chapter 6 described and 
discussed the framework design in details to addresses research hypothesises of  
3. The framework can be demonstrated to support clinical process improvement 
4. The framework can be demonstrated with the healthcare setting where clinical 
practice is routinely taking place in different cultural settings 
5. The framework can be used to support the measurement of the effectiveness of the 
clinical decision support system to support clinical decision making and improve 
healthcare outcomes  
Through full description of the case study, chapter 6 instantiated that the objectives of the 
research have been met by the proposed framework, with those being: 
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1. A well-constructed quality improvement research framework have been designed by 
extending the SPO model, in combination of the CRISP-DM model and the PaJMa 
model  
2. The framework has been demonstrated through a case study in cross-cultural 
settings 
3. The effectiveness of the clinical decision support on clinical outcomes  
4. The Artemis analytic system has capability in detecting early changes in the high 
frequency physiological streams in suspected neonatal sepsis has been demonstrated 
by the case study 
7.2 Clinical Implications  
Although QI has received much more attention in the past two decades than ever before, 
most of them through methods such as increase patients’ and employees’ satisfaction et al 
(Baker, et al, 2003), implementation of multi-intervention including evidence-base 
practice (Scales, et al, 2011), staff education (Ferrer, et al, 2008), utilization 
organizational assessment survey (Baker, et al, 2003), and increase leadership (Horbar, et 
al, 2003). Questions such as how to maximum utilize of IT resource to improve QI and in 
which degree of IT to QI remain under study. 
CDSSs have played key roles in supporting healthcare in many aspects, such as helping in 
the analysis of patient data to determine diagnosis of disease. In the modern critical care 
environment such as NICUs, due to the nature of infants’ inability of providing symptoms 
to clinicians; in addition to analyze clinical signs and symptoms, clinicians have to rely 
on analysis of laboratory tests results and physiological data collected from medical 
devices attached to infants to assist them determine disease diagnosis thus make proper 
treatment plan to treat sick infants, to ensure quality of care provide to infants. However, 
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many doctors and nurses have no confidence in understanding and analyzing the acquired 
data from the medical devices in the NICU to make their decision, other than rely on IT 
professionals and/or the CDSS to assist them for clinical decision making.  
In the NICU environment, from a health informatics perspective, one way to assist 
clinicians to predict and diagnose diseases on time is to implement the CDSS to analyze 
patient data in real-time to ensure quality of care delivered. In this research, the 
framework is designed through the implementation of the CDSS that is able to obtain and 
analyze of patient data in real time to support clinical decision making to improve the 
clinical process. Many factors have been taken into consideration when designing this 
framework for QI, including: differences in medical equipment used; data used for 
analysis; different culture beliefs and values; attitude toward narcotics use for infant pain 
management; and NICU physical working environment.  The QI framework is expected 
to have positive impact on improving clinical process and outcomes, increase efficiency 
and increase effectiveness of the CDSS in cross-cultural clinical settings. The research 
results should be recommended for use as a new practical model and an example to 
implement in real acute clinical settings to improve clinical process thus to improve 
quality of care.  
7.3 Contributions of the Framework 
This is a unique action research design, the contributions of the proposed framework are: 
1. Definition of a QI framework in NICU for further research to ensure QI outcomes 
2. Extensions to a SPOE clinical practice model for clinical process improvement to 
improve quality and outcomes in the NICU by utilizing and analysis of real-time 
physiological data  
3. Enables the integration of CRISP DM and the PaJMa for QI framework   
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4. Evaluation of the CDSS through analysis of acquired physiological data in real-time  
5. The PaJMa model has significant impact on improve clinical process thus improve 
quality  
6. Demonstration using a clinical case study  
7.4 Limitations 
Clinical research is an on-going process made more complex, given slight different 
clinical practices in two different cultural background hospitals. In addition to the need of 
having substantial time and resource needed to conduct a trials, particularly in the area of 
NICU, this trial may not be unable to enrol sufficient patients for adequate statistical 
power to conduct a RCT to evaluate the CDSS.  
Second, for many clinical informatics interventions, the potential effect on patient 
outcomes is affected by clinician behaviors; such as if the clinician does not use the 
intervention, the patient cannot reap the benefits (Bakken, 2009).  Therefore, in China, the 
lack of using ECG to support this research may lower research results. Finally, the 
difference in clinical practice behaviour can also affect the research, for instance, the 
routine of using narcotics for pain management in Canada will have slight difference 
research result compare with in China where using narcotic in infants is not a routine 
practice.  
7.5 Impact and Further Research  
The significance of the QI framework design and success according to defined QI has 
been described in previous chapters. Although there are a few differences in terms of 
routine clinical intervention in cross-cultural settings; including the difference in clinical 
contexts and current practical models; difference in resource allocation such as the health 
information management and laboratory system are not integrated with the CDSS in 
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Chinese setting but it is in The Hospital for Sick Children Toronto, the framework will 
have positive impact on QI in the NICUs.   
In terms of future research, potential and possibility of using the randomized control trial 
research methodology to evaluation the CDSS as an innovation in evaluating the 
application of IT in healthcare domain is next research area. Moreover, cultural belief has 
impact on supportive of QI: values, beliefs, and norms present in the microsystem that 
emphasise teamwork, communication, freedom to make decisions and commitment to 
improve. In China, clinicians do not use narcotics such as morphine for post-operative 
pain management; usually they use Tylenol to control pain; therefore, how and in which 
degree of pain effect on physiological data changes is another potential research 
opportunity.    
7.6 Conclusion 
QI is a complex concept that consists of components of safe, effective, patient-centered 
care, timely, efficient, and equitable (Committee on Quality of Health in America, 2001). 
Many QI initiatives have accelerated in the past two decades; however, most of them 
focused on increasing patient and employee satisfaction and improving process of caring 
(Curtis, et al, 2006; Kaplan, et al, 2012). It is unfortunate that there is lack of study on 
implementation of CDSSs to improve QI, especially in an acute care setting such as 
NICU environment (Fan, et al, 2010; Kaplan, et al, 2012).  
This thesis presents a framework design for implementation and evaluation of the CDSS 
to improve QI in NICU in cross-cultural settings. The proposed framework extends an 
existing SPO model to SPOE model through implementation of the CDSS, and the 
integration of CRISP-DM and the PaJMa model to improve clinical process thus assist 
clinical decision making, finally reach QI goals of patient-centered care, timely, increase 
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efficient and effective. This thesis has demonstrated capturing, storage, and analysis of 
patient physiological data will support QI and evaluation of effectiveness of the CDSS. 
The designed framework will continue with its future investigation in the post narcotics 
pain management as next step of QI research, as to measure degree of pain effect on 
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Appendix 1:  Extended the CRISP-TDM to incorporate multi-dimensional data 
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